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Background: The overarching objective of public health policy in Sweden has a clear focus 
on equitable health throughout the population and includes a commitment to reduce avoidable 
health inequalities. Trans (transgender) people constitute a population that is highly affected 
by social and health inequalities. People living with HIV in the era of effective antiretroviral 
therapy (ART) with full access to treatment can live long, fulfilling and productive lives, yet 
social conditions such as stigma and discrimination continue to contribute to negative health 
outcomes.  
Aim: This project studies quality of life (QoL) and sexual health in two populations: trans 
people and people living with HIV.  
Methods: Data for this thesis is derived from two large cross-sectional studies, targeting 
people living with HIV (Paper I–II) and trans people (Paper III–IV). In 2013-2014, a nation-
wide representative study was conducted in 17 infectious disease clinics and needle exchange 
programs across Sweden (Paper I–II) (n=1097). For studies III–IV, data was collected via a 
web-based survey targeting trans people in Sweden in 2015 (n=796).  
Results: In Paper I, we found that QoL among people living with HIV included in the study 
was high overall. Lower QoL was associated with having comorbidities, internalized stigma, 
hopelessness and experiencing negative changes to sex life after HIV diagnosis. In Paper II, 
we examined the direct and indirect associations between sexual satisfaction and contributing 
factors among people living with HIV. Sexual dissatisfaction was reported among 49% of 
respondents. Path analyses revealed that, among both women and men, negative changes to 
sex life after the HIV diagnosis were directly associated with sexual dissatisfaction. In 
addition, not being involved in an intimate relationship and perceiving the obligation to 
disclose HIV status to sexual partners as a barrier to finding a long-term partner were 
indirectly associated with sexual dissatisfaction. In Paper III, it was found that self-rated 
health, self-reported disability and QoL among trans people included in the study were 
associated with experiencing negative or incompetent healthcare experiences. In addition, 
poorer health outcomes were associated with limited access to legal gender recognition and 
with identifying as non-binary. The results from Paper IV indicated that sexual satisfaction 
was relatively low among respondents (46%) and was associated with having multiple current 
sexual partners, satisfaction with partner relationship, absence of negative mood symptoms, 
possibilities to discuss sexual matters in healthcare context and no history of sex in exchange 
for money. In addition, results revealed generally low condom use and HIV testing, both 
motivated by low risk perception, lack of knowledge of trans-friendly clinics and sexual 
practices that do not require a condom. 
Conclusions: Despite good treatment outcomes and generally high QoL, people living with 
HIV face stigma, poor mental health and various sexual health challenges that have a bearing 
on people’s QoL and sexual satisfaction. Factors related to trans people’s health and QoL are 
similar to those of the general population in addition to trans-related distal factors such as 
legal gender recognition and experiences of healthcare incompetence in trans-related issues.  
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PREFACE  
In 2014, I was a research assistant at the Department of Public Health Sciences at Karolinska 
Institutet and became involved in the study ‘Living with HIV in Sweden’ (‘Att leva med hiv i 
Sverige’) – a nation-wide study about the quality of life (QoL) of people living with HIV in 
Sweden. Anna Mia Ekström, who was the principal investigator for the project, recruited me 
to help with data collection. Later, in the autumn of 2015, I was involved in a second project, 
“Health for all”– a study about the health and health determinants of trans people in Sweden. 
As a research assistant in the project, I was involved from the early stages of study design and 
my role was to coordinate the project. In the process of developing the questionnaire, we 
incorporated instruments concerning QoL and sexual health that were similar to those we 
used in the study ‘Living with HIV in Sweden’. Since I was interested in a PhD position and 
as I was involved in both projects, I saw an opportunity to study QoL in two very different 
groups of people, trans people and people living with HIV. Both groups are exposed to 
prevailing stigma and discrimination in our society. 
 
I am by no means inferring that one can or should compare trans people with people living 
with HIV. Being trans is related to a person’s identity while HIV is an infection, a diagnosis, 
and a person living with HIV does not necessarily see their HIV diagnosis as a part of their 
identity. However, social determinants of health are similar for all people regardless of their 
gender identities and health status. Moreover, disparities in health and wellbeing are often 
seen as, besides biological factors, a result of social inequalities. Thus, health outcomes are 
largely shaped by social, economic, behavioral and structural factors which can often be 
targeted through policy. This is my point of departure in this project.  
 
These studies were conducted with the financial support of the Public Health Agency of 
Sweden. The studies included here also constitute the largest self-reported surveys conducted 
in Sweden to date among people living with HIV and among trans people. I would like to 
thank each and every respondent in this project: all 1,100 respondents in the study “Living 
with HIV in Sweden” and the 796 respondents in the study “Health for all”. It is thanks to 
your willingness to share your experiences that research like this is possible. I hope this thesis 
can be useful in providing an updated picture of the different aspects of life that are important 
to be targeted when attempting to improve overall QoL among people living with HIV and 
trans people.  
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1 BACKGROUND  
1.1 QUALITY OF LIFE  
1.1.1 The concept of quality of life  
Quality of life (QoL) is a concept that lacks a uniform definition and there is no “gold 
standard” on how to assess it. Generally, QoL can be described as feelings of happiness, 
satisfaction, contentment with life and the ability to cope [1,2]. Some researchers have tried 
to conceptualize QoL. For instance, Calman (1984) proposed the expectation model, which is 
a measure of the gap between an individual’s aspirations, hopes and goals and the 
individual’s actual experiences [1]. Hörnqvist (1982) argued that an individual’s QoL is a 
result of the need satisfaction within six main spheres of life: structural, material, activity, 
social, physical and psychological [3]. Despite various conceptualizations and 
operationalizations of QoL, there is a general belief that most people are familiar with the 
expression ‘quality of life’ and have an intuitive understanding of what it comprises [2]. In 
addition, there is a consensus among researchers that QoL should be subjectively evaluated 
and that it is a multidimensional concept, incorporating different life aspects [2].  
 
Unlike QoL, the term health-related quality of life (HRQoL) is more specific [2]. HRQoL can 
be used as a clinical assessment tool in different patient groups as well as for people without a 
health-related condition. Although HRQoL, similarly to QoL, lacks a single definition, it 
often incorporates aspects and assessments of general health and physical, emotional and 
social functioning [2]. Many HRQoL instruments focus on health status, functional status and 
a variety of symptoms (e.g. pain, fatigue, insomnia, anxiety, etc.). These assessments are 
appropriate for clinical purposes when comparing different therapies and aiming to reduce 
toxicity and symptoms [2]. QoL entails more than physical aspects of health, which is why 
most instruments cover aspect related to emotional and social functioning [2]. For example, it 
has been shown that patients with cancer, while reporting some decline in satisfaction within 
various life domains, reported similar general QoL compared to the general population [4]. 
This and similar findings could be explained by the assumption that QoL is a relative and 
dynamic concept – it changes and adapts over time, according to different individual 
aspirations and circumstances [4]. Calman (1984) explains that people who might seem to 
have major problems, including a serious health condition or disability, are still able to have 
good QoL. They are able to achieve this either by adjusting their expectations to a new life 
situation and thus narrowing the gap between their expectations and achievements, and/or by 
their ability to rise above the problems through personal growth and personal development 
[1].  
There are many different instruments that can be used for QoL assessments. Some are generic 
and can be used to assess QoL among various populations with or without a health condition 
or disability [2]. The most commonly used generic instruments combine assessments of 
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physical, social and emotional functioning (such as the SF-36 and EQ-D5) where respondents 
choose their response from a set of alternatives [2]. These instruments vary in length and 
dimension and at what level of detail they assess QoL [2]. Other instruments are disease-
specific and are used to assess QoL in different groups, such as patients with cancer. These 
instruments usually include assessments of a variety of specific symptoms in addition to 
functional and overall health [2].  
 
As mentioned above, QoL is assessed differently depending on the definition and 
conceptualization used. While some studies use instruments that are designed to assess 
HRQoL, others use instruments designed to assess overall or general QoL, and might use a 
single item for that assessment. In this project, the assumption is that QoL is a subjective, 
multidimensional and context-specific concept. It means different things for different people 
and during different periods in life. In addition, it is related to various life domains which are 
also very contextual.   
 
1.2 SEXUAL HEALTH AND SEXUAL SATISFACTION 
According to the World Health Organization’s (WHO) definition, sexual health is “…a state 
of physical, emotional, mental and social well-being in relation to sexuality; it is not merely 
the absence of disease, dysfunction or infirmity. Sexual health requires a positive and 
respectful approach to sexuality and sexual relationships, as well as the possibility of having 
pleasurable and safe sexual experiences, free of coercion, discrimination and violence. For 
sexual health to be attained and maintained, the sexual rights of all persons must be respected, 
protected and fulfilled” [5]. 
 
Despite this holistic definition, sexual health is often discussed as a unidimensional concept 
and discussed in terms of sexually transmitted infections (STI). Recently, there has been a 
positive shift to a rights-based approach to sexual (and reproductive) health and a new, 
integrated definition of sexual and reproductive health and rights (SRHR) was adopted by the 
Lancet Guttmacher Commission. This definition emphasizes that “…..a positive approach to 
sexuality and reproduction should recognize the part played by pleasurable sexual 
relationships, trust, and communication in the promotion of self-esteem and overall 
wellbeing”  [6]. The same integrated definition of SRHR spells out sexual satisfaction as a 
sexual right by saying that all individuals have the right to “have safe and pleasurable sexual 
experiences” [6].  
Sexual satisfaction is thus an important aspect of sexual health. It is further associated with 
overall well-being and QoL [7,8]. The concept sexual satisfaction is a subjective and context-
specific construct. There are various definitions to sexual satisfaction but the most commonly 
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used one is proposed by Lawrance and Byers (1995) who defined sexual satisfaction as “an 
affective response arising from one’s subjective evaluation of the positive and negative 
dimensions associated with one’s sexual relationship” [9]. 
 
As there are various definitions of sexual satisfaction, there are consequently many different 
assessment instruments. A systematic review of 197 studies concerning sexual satisfaction 
found that over 40 different instruments were used to asses sexual satisfaction [7]. The 
assessment of sexual satisfaction varies across studies; in most studies, it is measured in a 
relational perspective [7]. The most commonly used instruments include assessments of 
magnitude of a problem with dyadic relationship [10], or the assessment of different 
dimensions of sexual relationships with a partner [9]. Other scales assess not only relational 
but also individual and behavioral aspects of sexuality and measure constructs such as sexual 
sensations, sexual presence and awareness, sexual exchange, emotional connection or 
closeness and sexual activity [11]. In addition, some instruments are more focused on sexual 
function and assess aspects such as erectile dysfunction [7]. Other instruments use a global 
single question assessing self-reported satisfaction [7].  
 
Henderson et al. (2009), conceptualized sexual satisfaction with the help of the socio-
ecological theory, explaining that sexual satisfaction is the outcome of the interaction 
between proximal and distal factors. According to this conceptualization, sexual satisfaction 
is related to the interaction between the microsystem (individual level factors such as beliefs, 
values and emotions), the mesosystem (intimate relationships), the exosystem (social support 
and extended family) and the macrosystem (laws, ideologies and cultural beliefs) [12].  
In this study, we adopt the idea that sexual satisfaction is a subjective, multidimensional 
concept which is context-specific. It is a result of various factors related not solely to dyadic 
relationship but also to individual and societal factors.  
 
1.3 LIVING WITH HIV  
1.3.1 Global HIV epidemiology  
According to the latest report by The United Nation’s Programme on HIV/AIDS (UNAIDS), 
an estimated 36.9 million (31.1–43.9 million) people are living with HIV globally [13]. 
Among people with a known HIV diagnosis worldwide, 21.7 million (19.1–22.6 million) 
have access to antiretroviral treatment (ART) [13]. Since the peak of the epidemic in 2005, 
AIDS-related deaths have declined by nearly half, yet AIDS-related deaths still constitute a 
substantial global burden, despite very effective ART and 940,000 people (670,000–1.3 
million), an unacceptably high number, are estimated to have died of AIDS-related causes in 
2017 [13]. Most of these deaths occurred in Sub-Saharan Africa, albeit with great regional 
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and national differences. The incidence of HIV has been declining globally since 2000 while 
the number of people living with HIV has been increasing thanks to increasing access to 
effective ART [14]. 
 
1.3.2 HIV epidemiology in Sweden  
Sweden is a low-endemic country with an HIV prevalence of about 0.07%. It is estimated 
that approximately 7,749 people are living with a diagnosed HIV in Sweden [15] (39% 
women, 61% men) and between 400–500 individuals are newly diagnosed with HIV each 
year [16]. The majority of people living with HIV in Sweden have contracted HIV through 
heterosexual intercourse, either on trips abroad or before migrating to Sweden. While sex 
between men remains the most common transmission mode domestically, migrants constitute 
the largest proportion of newly diagnosed cases in Sweden since 1990, and accounted for 
more than 80% of diagnosed cases in 2017 [16]. According to the national quality registry 
InfCare HIV in December 2018, 50.6% of people living with HIV in Sweden contracted HIV 
via heterosexual sex, 31.3% via sex among men, 5.1% via injecting drug use, 2.9% via 
mother to child, 1.4% via blood products and 5.9% from another/an unknown source [15].  
 
1.3.3 The UNAIDS 90-90-90 targets of treatment cascade  
The UNAIDS announced new ambitious targets for the global response to HIV in 2014. 
These targets, called the 90-90-90 targets, call for countries to, by 2020, ensure that 90% of 
people living with HIV will know their HIV status, 90% of people who are diagnosed with 
HIV receive sustained ART and that 90% of people living with HIV who receive ART will 
achieve viral suppression [17]. The 90-90-90 targets emerged thanks to the fact that viral 
suppression, as a consequence of access to effective ART, has great benefits both for the 
individual living with HIV through greatly improved healthy survival as well as for the entire 
population by reducing the risk of secondary transmission to sexual partners and from mother 
to child by at least 96% [17]. Globally, the progress towards the 90-90-90 targets is slow but 
is going in the right direction, even though some countries have had greater progress than 
others. According to UNAIDS reporting from 2018, three out of four people (55–92%) living 
with HIV knew their HIV status in 2017. Among those who knew their HIV status, 77% (57–
89%) were accessing ART, and 82% (6089%) of people on treatment had suppressed viral 
loads [17]. The global progress towards the 90-90-90 targets includes challenges related to 
each element of the treatment cascade, beginning with knowledge about HIV and HIV 
diagnosis, linkage to care and retention in care and finally viral suppression. All of these 
aspects are challenged by weak health systems, lack of access to effective treatment and 
stigma and discrimination, among others [17]. 
Sweden was the first country in the world to reach the UNAIDS 90-90-90 target [18]: it is 
estimated that 90% of HIV cases are diagnosed, 97.5% of diagnosed people living with HIV 
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are linked to care and 95.3% on ART have achieved viral suppression [15] (Figure 1). 
Despite these encouraging numbers, the HIV epidemic in Sweden is also characterized by a 
large proportion of people who are diagnosed late (when CD4 count <350 cells/ml or the 
person has already been diagnosed with an AIDS-defining illness) [19,20]. It is estimated that 
approximately half of the annual HIV diagnoses are among late presenters, which is more 
prominent among foreign-born and older age groups [21]. 
 
 
Figure 1. The UNAIDS 90-90-90 targets adjusted for the Swedish treatment cascade in 
December 2018 (based on data from the national quality registry InfCare HIV [15]) 
 
1.3.4 HIV treatment and management–then and now  
Since it was first discovered in the early 1980s, the discourse about HIV and AIDS, which for 
a long time were used synonymously, has changed tremendously. During the 1980s, an HIV 
diagnosis was equivalent to a death sentence. The early 1980s were also characterized by 
large misunderstandings and misconceptions about the biology, source and epidemiology of 
HIV and AIDS [22]. In 1987, the first drug for the treatment of HIV was introduced – 
azidothymidine (AZT). This drug later proved ineffective as patients quickly developed drug 
resistance [22]. By 1991, monotherapy of HIV/AIDS had shifted to combination therapy with 
newer drugs (didanosine [ddi] and zalcitabine or [ddC] for short) in combination with AZT 
[22].  A breakthrough in the treatment and the prognosis of HIV occurred in 1996, with the 
introduction of highly active antiretroviral therapy (HAART) – a triple drug treatment, 
containing protease inhibitors [22,23]. HAART had a quick and significant impact on the 
health and survival of people living with HIV. The new treatment reduced the risk of 
opportunistic infections and morbidity through suppression of viral replication and by 
increasing CD4 cell counts, consequently extending survival [23]. The new treatment was 
referred to as ‘miraculous’ and the effect it had on patients was so tremendous that it was 
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seen as an opportunity for a ‘second life’ [23]. Today, antiretroviral treatment (ART) is 
potent, convenient – usually entails one to two pills a day, and usually well tolerated [24,25].  
 
ART can reduce the concentration of the HIV virus in the blood to undetectable levels within 
weeks of treatment initiation, which increases CD4 cell counts and survival among people 
living with HIV [24]. The effect of ART on the reduced risk of transmission of HIV became 
widely accepted in 2008 when a group of HIV experts released what is now known as the 
Swish Consensus Statement [26]. The statement was based on the conclusion that people 
living with HIV, who achieve viral suppression and have durable undetectable levels of virus 
in the blood (HIV RNA <40 copies per mL), cannot transmit the virus through sexual contact 
[27]. Today, there is scientific consensus that the risk of sexual transmission of HIV is nearly 
non-existing when a person who is living with HIV is durably virally suppressed and has 
condomless sex with a person who is HIV-negative. This important realization is a result of 
three large studies conducted among heterosexual couples and couples including men who 
have sex with men (MSM) between 2007 and 2016 that found no HIV infections among the 
HIV negative partners in HV discordant couples where the positive partner was on successful 
ART (virally suppressed) [28–30]. This incredible effect of ART is something that many 
people living with HIV worldwide are experiencing and as a result, a new term has emerged 
– undetectable=untransmittable, or for short – U=U. 
 
1.3.5 Living with HIV–biomedical, social and legal realities  
Despite significant progress in treatment and prognosis, HIV remains much more associated 
with stigma and discrimination than most other chronic health conditions [31]. Once on 
effective treatment and virally suppressed, the management of HIV in Sweden is mostly done 
by the person living with HIV him/herself, by taking daily an ART dose and many people 
living with HIV only visit their doctor once or twice a year. The social management of HIV, 
however, takes place ‘outside the clinic’, in the social sphere [31]. In a qualitative study 
conducted in the United Kingdom in 2016, people living with HIV shared ambivalent 
experiences of HIV as a condition that is not special as well as experiences of fear, stigma 
and shame [32]. The history and the historic discourse of HIV, the stigma that is still 
associated with HIV and its chronic nature, make HIV different from many other conditions 
[27,32]. Different social aspects of life are affected by an HIV diagnosis. People living with 
HIV face challenges related to intimate relationships, sexual challenges, disclosure concerns 
and criminalization of non-disclosure [31,33,34] that differentiate HIV from many other 
chronic conditions. People living with HIV are also faced with reproductive dilemmas which 
are multifaceted and include the person’s health status, fear of HIV transmission to child or 
partner, and restrictive or enabling policies that are in place [35–37]. In Sweden, for example, 
the majority of in vitro fertilization (IVF) clinics still do not provide IVF services for people 
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living with HIV, despite the nearly non-existing risk of transmission from mother to child 
under the conditions of effective treatment [38]. 
 
1.3.6 Quality of life among people living with HIV  
Today, the life expectancy of people living with HIV with universal access to ART is 
approaching that of the general population [39]. Research reports suggest that the QoL of 
people living with HIV on ART is relatively high [40–42], however lower than the QoL of 
people without HIV, mostly with regard to psychosocial aspects [43,44]. One study, which 
compared the HRQoL of people living with HIV to that of people with other chronic 
conditions (diabetes type 1, 2 and rheumatoid arthritis), found that while physical HRQoL 
was similar between the different groups, mental HRQoL was lower among people living 
with HIV [45]. Furthermore, a large study from England found that people living with HIV 
reported lower QoL compared to the general population, even after adjusting for 
sociodemographic variables and immunological status, antiretroviral therapy and viral load. 
These reported differences were only prevalent with regard to reported depression and 
anxiety [43].  
Research suggests that various sociodemographic, clinical and psychological factors are 
associated with the QoL of people living with HIV [46]: 
 
1.3.6.1 Sociodemographic factors  
Similarly to the general population, certain sociodemographic factors are also significant with 
regard to QoL among people living with HIV. It has been suggested that older age is 
associated with poorer QoL [47–49]. With regard to gender, studies have found gender to be 
significantly associated with QoL [40,44,47,50]. Unemployment [42,51,52] and financial 
constraints [40,53] are also reported to be significantly associated with lower QoL. Findings 
about the associations between partner relationship, children and QoL have been inconsistent 
(for review see [46]). Studies also suggest that living conditions, including housing 
conditions, are important to consider with regard to QoL and other health outcomes among 
people living with HIV. One systematic review from 2016, which investigated the health 
outcomes and the living situation of people living with HIV in high-income countries, 
revealed that unstable housing conditions and homelessness are significant barriers to HIV 
care, access and adherence to ART and sustained viral suppression [54]. Substance use and 
hazardous consumption of alcohol are other factors found to be associated with lower QoL 
among people living with HIV [42,46].  
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1.3.6.2 Clinical factors  
Clinical factors associated with lower reported QoL include comorbidities [40,42,48], early 
calendar diagnosis with HIV [43,53] and symptoms of HIV [42]. As people living with HIV 
age as a result of effective treatment, other health-related issues become relevant including 
increasing prevalence of chronic comorbidities [55–58]. Common comorbidities include 
cardiovascular diseases, kidney disease and various cancers [55–58], among others. Studies 
from different settings have shown that the prevalence of age-associated comorbidities is 
significantly higher in people living with HIV [55–57]. These conditions are also thought to 
have an effect on the overall QoL [58]. The reasons behind these elevated risks, particularly 
of cardiovascular comorbidities among people living with HIV, are not fully understood but 
are thought to be partly explained by a complex interaction between the viral infection, ART 
and other traditional risk factors such as smoking, hypertension, hyperlipidaemia, obesity and 
others [59,60]. 
 
1.3.6.3 Mental health and psychological factors  
Viral suppression has become the main indicator of health and treatment success among 
people living with HIV and as a result mental health conditions among people living with 
HIV receive insufficient attention [61]. It is estimated that the prevalence of clinical 
depression is two-to-fourfold higher among people living with HIV compared to the general 
population or to people without HIV (for review, see [62]). The association between HIV 
infection and depression is complex and depression is both a risk factor for HIV infection, as 
well as a potential consequence [62]. A combination of risk factors, including social stressors 
and stigma, ART side-effects and comorbidities are thought to contribute to increased 
prevalence of depression among people living with HIV [62]. In addition, other mental health 
conditions, including anxiety, are reported among people living with HIV. One systematic 
review from 2014 which assessed the prevalence of depression and anxiety among people 
living with HIV on ART estimated that between 21% and 40% of people living with HIV on 
ART experience anxiety [61]. Other mental health conditions among people living with HIV 
include post-traumatic stress (PTS), which is defined as a lasting mental condition associated 
with exposure to a traumatic life event which individuals may re-experience [63]. HIV 
diagnosis is, for some, a traumatizing life event and it is documented that people living with 
HIV report relatively high rates of PTS [63].  
 
1.3.6.4 Stigma 
Besides various mental health concerns, HIV-related stigma is another significant 
psychosocial factor affecting the QoL of people living with HIV. Even today, more than three 
decades since the beginning of the epidemic, HIV-related stigma continues to affect 
prevention [64,65], treatment [66–68] and the lives of people living with HIV [69–73]. HIV-
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related stigma is manifested by different mechanisms: stigma can be anticipated, enacted and 
internalized [74]. Anticipated stigma refers to expectations of prejudice, discrimination and 
stereotyping in the future by others because of one’s HIV status. Enacted stigma refers to 
experience of prejudice, discrimination and stereotyping from others due to one’s HIV status 
and internalized HIV stigma relates to the internalizing and endorsing of the negative beliefs 
and thoughts associated with HIV on oneself [74,75].  
 
HIV-related stigma has been associated with a range of adverse health and social outcomes 
including depression, limited social support, lower QoL and poor physical health (for review, 
see [76]). The understanding of the mechanisms in which stigma is manifested and how it 
affects the health of people living with HIV is not fully understood, however it is suggested 
that different mechanisms of stigma may have different effects on health [75]. A recently 
published thesis examining contemporary experiences of HIV-related stigma in Sweden [77] 
concluded that despite the favorable medical conditions that Sweden offers, HIV-related 
stigma still prevails. The most common type of stigma reported among people living with 
HIV was disclosure concerns [71]. In addition, it was found that while people living with 
HIV who are virally suppressed did not necessarily experience enacted stigma, they still 
feared disclosure [77]. A qualitative study conducted in Sweden in 2017 found that people 
living with HIV who are virally suppressed experience HIV-related stigma in a complex way; 
although HIV had very little impact on participants’ health, stigma still played a significant 
role on the participants’ life [77].  
 
There are numerous instruments used to assess HIV-related stigma [74]. According to a 
systematic review from 2016 [76], the most commonly used instrument to assess HIV-related 
stigma is the HIV stigma scale by Berger et al. [78], which is also used in the current study to 
assess four dimensions of stigma: personalized stigma, disclosure concerns, concerns about 
public attitudes and negative self-image [78].  
 
1.3.7 Sexual health and sexual satisfaction among people living with HIV 
HIV is a sexually-transmitted infection (STI) and that fact is particularly relevant in sexual 
situations.  People living with HIV face various challenges related to their sexual life, which 
may in turn also affect overall QoL. Although viral suppression and significantly reduced risk 
of transmission as a result of effective treatment is the reality for many people living with 
HIV, fear of HIV disclosure and fear of rejection are some of the challenges people living 
with HIV face [33,34].  
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1.3.7.1 Disclosure of HIV status to sexual partners  
According to the Swedish Communicable Disease Act, HIV is a notifiable disease and up 
until 2013, all people living with HIV were obliged to disclose their HIV status to sexual 
partners (see below “Medical and legal environment for people living with HIV in Sweden”). 
This legal obligation can have negative consequences for people living with HIV. A Swedish 
qualitative study from 2008 which explored how young adults living with HIV experience the 
Swedish Communicable Disease Act, found that people “turned off” their sexuality due to 
fear of disclosure and rejection [79]. It was previously found in Canada, where non-disclosure 
of HIV to sexual partners is also a criminal act, that this obligation negatively affected the 
possibilities of people living with HIV to have fulfilling sexual relationships [80]. Canadian 
qualitative studies [81,82]  have found that, as a consequence of Canadian criminalization of 
HIV non-disclosure to sexual partners, some people living with HIV withdraw from sexual 
activity due to fear of HIV transmission, anxiety, uncertainty, fear of abandonment, and loss 
of ability to engage in fulfilling sexual relationships. 
1.3.7.2 Sexual activity  
Previous research found that sexual inactivity is frequently reported among people living with 
HIV [80,83–88] and is thought to be a coping strategy to deal with various challenges 
including HIV-related stigma and fear of HIV disclosure [80]. 
  
1.3.7.3 Sexual function 
Another potential threat to the sexual health of people living with HIV is changes in sexual 
functions (desire, arousal and orgasm) [89–91]. This is similarly to sexual dysfunction in 
other chronic health conditions, such as diabetes, heart disease and urinary tract disorders 
[91,92]. The background to sexual dysfunctions is multifactorial where biological, emotional 
cognitive, interpersonal and contextual factors interact [91,93]. 
 
1.3.7.4 Sexual satisfaction  
Due to the above-mentioned sexual challenges,  a high proportion of people living with HIV 
report sexual dissatisfaction [80,83,84,86,87]. Studies comparing sexual dissatisfaction 
between people living with HIV and people without HIV found that dissatisfaction was 
higher in the former group [84].  
 
Several sociodemographic and psychosocial factors have also been identified as contributors 
to sexual satisfaction among people living with HIV. These factors are also identified as 
being related to sexual satisfaction in various populations [7] and include unemployment 
[83,84], not having a steady relationship [83,94], low self-efficacy and social exclusion [86], 
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and feelings of loneliness [83,84]. Depression and anxiety were also found to be associated 
with sexual dissatisfaction [95] and with sexual functioning among people living with HIV 
[91]. 
 
1.3.8 Medical and legal environment for people living with HIV in Sweden  
In Sweden, care for people living with HIV is free of charge and centralized to about 30 
infectious disease clinics across the country. All people diagnosed with HIV are linked to 
specialized HIV care which include a team of specialist physicians, nurses and, most often, 
counsellors. ART is covered by the national health insurance and is free of charge upon 
prescription [18]. Generally, people living with HIV in Sweden with sustained viral 
suppression (95.3% of people living with HIV in Sweden in 2018 [15]), only need to visit 
their designated infectious disease clinic annually or biannually for routine check-ups. 
1.3.8.1 The Swedish Communicable Disease Act  
In Sweden, HIV is a notifiable disease and has been subject to mandatory partner notification 
since 1985, as regulated by the Swedish Communicable Disease Act (SFS 2004:168) [96]. 
Up until 2013, people living with HIV were obliged to disclose their HIV status to sexual 
partners, regardless of condom use or viral suppression status. However, adoption of the 
evidence of minimal sexual transmission risk in patients who are durably virally suppressed 
[97] has led to modifications in the application of this obligation. Since 2013, individual 
HIV-physicians have been able to exempt patients from disclosing their HIV status to sexual 
partners, provided that they fulfil the requisite criteria: adherence to medical visits and 
monitoring; sustained viral suppression (at least two repeated undetectable viral load 
measurements in the last 12 months; and unconditional condom use [97]. In practice 
however, additional exemptions are made in clinical practice, for example when discordant 
couples try to become pregnant. Despite the recent modifications, the law itself still exists and 
affects people living with HIV. The awareness of the modified implementation of the law is 
also insufficient among healthcare personnel as well as among people living with HIV. This 
was shown in a recent 2018 report by the Public Health Agency of Sweden 
(Folkhälsomyndigheten) which revealed that 57% of the 318 people living with HIV 
surveyed, had a conversation with their doctor about the possibilities of exemption and 39% 
received this exemption to disclose HIV status to sexual partners [98]. This implies that 
despite the fact that >95% of people who are living with HIV in Sweden are potentially 
eligible to be exempted from this legal obligation, not all benefit from this in practice. 
 
1.3.8.2 The national HIV strategy  
The National Strategy to combat HIV/AIDS and certain other communicable diseases 
(Government Bill 2005/06:60), adopted by the Swedish Parliament in 2006 has one main 
goal – “to restrict the spread of HIV infections and other sexually-transmitted and blood-
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borne infections and to limit the consequences of these infections for society and the 
individual” [99]. The strategy was updated in 2016, due to the developments in effective 
treatment and the minimal risk of secondary transmission due to viral suppression [99]. One 
interim objective of the new strategy is to decrease HIV-related stigma and discrimination so 
that people living with HIV can disclose their HIV status without being discriminated against 
[99]. The strategy includes a new list of key populations who should receive extra attention 
both with regard to prevention and support. These key populations include men who have sex 
with men (MSM), people from high-endemic regions, people who inject drugs, trans people, 
young people and young adults and people in prostitution [99]. 
 
1.3.8.3 HIV Outcomes Initiative 
The HIV Outcomes Initiative is a European organization, created in 2016 as a result of 
cooperation between European experts who wanted to direct policymakers and healthcare 
providers’ attention to the importance of various health issues and social exclusion of people 
living with HIV [100]. The initiative focuses on prevention and management of comorbidities 
and the need for patient-centered healthcare delivery as strategies to improve the long-term 
prospects of people living with HIV to live healthy, productive and rewarding lives [100]. 
The HIV Outcomes Initiative developed a set of recommendations for policymakers and the 
health community that include health–system- and policy-related strategies to improve the 
long-term health and wellbeing of people living with HIV [100].  
Sweden is a part of this initiative and is often presented as a model country as regards the 
systematic and efficient monitoring of health and developments in patients living with HIV. 
Two well-cited examples are the national quality registry InfCare HIV and the delivery of 
cross-sectorial care to patients in, for example, the country’s second largest infectious disease 
clinic (Venhälsan, Södersjukhuset, Stockholm) [101]. 
 
1.4 TRANS PEOPLE  
1.4.1 Important terms and definitions  
Gender identity refers to a persons’ inner feeling of what gender they belong to [102] while 
gender expression is the outward presentation (clothes, hair, accessories, etc.) someone uses 
in order to be recognized by others as belonging to a certain gender [103]. Transgender 
(hereafter referred to as trans) is a self-defined umbrella term for people whose gender 
identity and/or expression differ from that assigned to them at birth [104]. Trans people may 
describe their trans experience as trans feminine, trans masculine, non-binary, crossdresser, or 
by other terms, see Table 1. In addition, trans people’s gender identity may be male, female, 
non-binary or other [105,106]. Some trans people have gender dysphoria. Gender dysphoria 
is distress caused by gender incongruence and one strategy to alleviate this is by gender-
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affirming medical interventions such as hormone therapy and/or surgery [107]. However, not 
all trans people need or desire gender-affirming medical treatment [108,109].  
 
Table 1. Glossary of trans-related terms that are mentioned in the thesis and in the individual 
papers  
Asexual  asexual is usually used to describe a person who never or during some 
periods does not feel sexual attraction, does not have sex or does not 
want to include others physically in their sexual practice.1  
Cisgender  A term used by some to describe people who are not transgender. "Cis-" 
is a Latin prefix meaning "on the same side as".2 
Cisnormativity  The assumption that all people identify themselves as the gender 
assigned to them at birth and live according to the gender social norms 
(feminine/masculine).1  
Cross-dresser The term cross-dresser is typically used to refer to men who 
occasionally wear clothes, makeup, and accessories culturally associated 
with women.2  
Gender dysphoria  Distress that gender incongruence might cause.3 
Gender expression The way one expresses gender by use of certain clothes, hairstyles, 
accessories, make-up and other attributes.3 
Gender identity 
 
A person's internal, deeply held sense of their gender. For transgender 
people, their own internal gender identity does not match the sex they 
were assigned at birth.2 
Gender incongruence  When a person’s gender identity and/or expression does not align with 
the sex assigned to them at birth.3 
Gender Non-
Conforming 
A term used to describe some people whose gender expression is 
different from conventional expectations of masculinity and femininity.2  
Gender-affirming 
healthcare  
Medical treatments aiming to alter the bodily characteristics in order to 
better align with the person’s gender identity and ease gender dysphoria. 
Examples of gender affirming healthcare include hormone treatment, 
hair removal, vocal training and surgery.3  
Gender-affirming 
surgery  
Surgeries aiming to change the body in different ways to better align 
with the person’s gender identity. Examples may include breast 
augmentation, breast removal (mastectomy), creating new genitals, 
removing gonads, etc.3 
Heteronormativity  Denoting or relating to a world view that promotes heterosexuality as 
the normal or preferred sexual orientation.4  
Legal gender The gender stated in legal documents, such as birth certificate and 
passport. Legal gender can, in some countries, be changed. Most 
countries only have two legal genders: male and female.3 
Legal gender 
recognition  
The process in which a person’s legal gender is changed to align with 
the person’s gender identity.3 
Non-binary/ 
genderqueer  
A person identifying outside of the gender binary. Not identifying as 
male or female, perhaps being in between or a whole other gender.3 
Sex The classification of a person as male or female. At birth, infants are 
assigned a sex, usually based on the appearance of their external 
anatomy.2 
Trans  Used as shorthand to mean transgender or transsexual - or sometimes to 
be inclusive of a wide variety of identities under the transgender 
umbrella.2  
Trans feminine  A person who was assigned male at birth, identifying or presenting as 
female or feminine.3 
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Trans masculine  A person who was assigned female at birth, identifying or presenting as 
male or masculine.3  
Transgender  An umbrella term for people whose gender identity and/or gender 
expression differs from what is typically associated with the sex they 
were assigned at birth.2 
Transphobia  An ideology or perception that expresses a strong negative view on 




An older term that originated in the medical and psychological 
communities.2  
Transvestite  In the Swedish context, the term ‘‘transvestite’’ is a term often used by 
people who belong to this group themselves. The term refers to 
individuals who always or periodically express their gender 
differently from the sex assigned to them at birth. Many, however, do 
identify with their assigned sex at birth when they are not cross-dressed.5  
1 RFSL. Glossary–Some LGBTQ terms and expressions explained. [Internet]. 2015. Available from: 
https://www.rfsl.se/en/lgbtq-facts/lgbtq/glossary/ 
2 GLAAD. Glossary of Terms - Transgender [Internet]. Available from: 
https://www.glaad.org/reference/transgender 
3  Zeluf G, Dhejne C, Orre C, Nilunger Mannheimer L, Deogan C, Höijer J, et al. Health, disability and quality 
of life among trans people in Sweden–a web-based survey. BMC Public Health. 2016;16(1):903.  
4 Oxford Dictionaries. Definition of heteronormative in English:  
5. Zeluf G, Dhejne C, Orre C, Mannheimer LN, Deogan C, Hoijer J, et al. Targeted Victimization and Suicidality 
Among Trans People: A Web-Based Survey. LGBT Health. 2018;5(3):180–90.  
 
1.4.2 Prevalence of trans people and gender dysphoria 
A systematic review from 2016 estimated the prevalence of self-identified transgender 
identity to be 0.3% (95% CI  0.1–0.6) [110]. Gender incongruence, defined as stronger 
identification with a different sex to the one assigned at birth,  was estimated in the adult 
populations of Belgium and the Netherlands [105,111] to be 0.7–1.1% of assigned males and 
0.6–0.8% assigned females at birth. Recently, a Swedish population study found that 2.3 % 
reported a feeling of gender incongruence measured in terms of the statement “I feel like 
someone of a different sex” [112]. In the same study, 0.6% of assigned males and 0.4 % of 
assigned females reported symptoms of gender dysphoria measured in terms of the statement 
“I would like hormones or surgery in order to be more like someone of a different sex” [112]. 
The prevalence of people who have undergone gender-affirming treatment and change of 
legal gender was estimated in Sweden in 2010 to be 1:15,047 assigned females and 1:8,636 
for assigned males [113]. As a comparison, the Netherlands reported in 2015 the prevalence 
of people who have undergone gender-affirming treatment to be 1:5200 for assigned females 
and 1:2,800 assigned males [114].  
 
Many countries have also reported an increase in people applying for gender-affirming 
healthcare [113]. The reason for this increase is unknown but reasons related to increased 
awareness and access to information, more tolerance in society, changes in diagnostic criteria,  
health care resources available and improved surgical outcomes, have been put forward as 
explanations [113]. 
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1.4.3 Trans people’s health  
Trans people are a population disproportionately affected by adverse health outcomes. Health 
inequalities among trans people are multifactorial and, besides being characterized by 
common health determinants affecting the general population, are also heavily related to 
social and structural determinants [115]. Some health concerns are related to exposure to 
prejudice, stigma, discrimination and targeted victimization [115,116]. Trans people 
experience a high burden of violence and victimization, including sexual, physical, verbal and 
emotional violence [115]. These vulnerabilities are directly and indirectly associated with 
multiple adverse health outcomes including depression [117,118], sexual risk behavior and 
higher rates of HIV infection (mainly among trans women) [119–121], substance use [122] 
and suicidality [123,124]. The indirect health outcomes of stigma and discrimination may 
also include avoidant coping strategies which are related to depression [118] or postponing 
seeking health care when needed due to fear of discrimination [125]. Limited access to 
adequate, trans-competent and sensitive healthcare is another determinant which may lead to 
poor health outcomes [125–128].  
Health concerns among trans people are also thought to be syndemic, i.e. health risks and 
adverse health outcomes are co-occurring and are largely determined by social inequalities 
[121].  These syndemics may include mental health conditions such as depression, violence 
and victimization, substance abuse and higher risk for STIs including HIV [121].   
 
1.4.3.1 Gender-affirming healthcare  
As mentioned earlier, not all trans people need gender-affirming care. In fact, a significant 
proportion of trans people report not needing medical gender-affirming interventions [129–
131]. In a Canadian study of 433 trans people, 23% were living in their felt gender without 
any medical interventions [129]. Similarly, in a large American study, including 6,456 trans 
respondents, 18% reported living full time in accordance with their gender identity without 
medical interventions [131]. With that said, for trans people with gender dysphoria, gender-
affirming medical intervention is essential in easing dysphoria and making the individual 
more gender congruent [132] and is therefore a key health determinant [115]. Access to 
gender-affirming healthcare varies tremendously between countries. In many countries, trans 
people are not recognized and in some countries trans people are even criminalized [133]. 
Besides juridical restrictions, gender-affirming health care depends on the fulfilment of 
specific treatment criteria, on health systems and health insurance coverage. In many 
countries, this type of healthcare is needed to be paid out-of-pocket and in other countries, 
strict gatekeeping might limit the access to needed healthcare [134].  Limited access to 
gender-affirming healthcare for trans people who need it may have negative social and health 
consequences including depression [135,136], increased discrimination [128], lower QoL 
[137] and increased suicidality [138]. Studies examining health outcomes in trans people after 
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undergoing gender-affirming interventions have found significant improvements in QoL 
[137], better self-esteem [139], higher job satisfaction, mental health and life satisfaction 
[140] and good physical and mental wellbeing [141]. 
 
1.4.3.2 Mental health  
Given the above-mentioned vulnerabilities, it is not surprising that mental health is the most 
commonly studied research area of trans people’s health [115]. Poor mental health, including 
depression and elevated suicide risk, is a commonly reported health concern among trans 
people [138,142–144]. Poor mental health is not always resolved by gender affirmation. This 
is supported in a large Swedish study from 2011 which investigated the rates of psychiatric 
morbidity and mortality among patients after gender-affirming surgery compared to matched 
controls [143].  The study found higher rates of death caused by suicide and cardiovascular 
diseases among patients who had undergone gender-affirming surgery [143].  This elevated 
suicidality could be explained by the fact that psychiatric morbidity is more prevalent among 
people applying for gender-affirming medical interventions [143].  While some psychiatric 
morbidity can be explained by gender dysphoria caused by gender incongruence per se, some 
are related to other challenges, that, if not addressed adequately, could remain even after 
gender-affirming treatment [145].  Studies have also found elevated rates of substance use 
among trans people [122].   
 
1.4.3.3 Other health determinants  
While certain health determinants are unique for trans people, most determinants are common 
for cisgender and trans people alike. However, some health determinants associated with poor 
health in the general population, such as unemployment and low income, may be elevated 
among trans people [146–148]. Age is another determinant of health which might be 
particularly important with regard to young trans people due to the increased vulnerability 
often reported among trans youth and young adults in particular with regard to exposure to 
victimization [149,150].  
 
1.4.4 Quality of life among trans people  
Earlier studies about the QoL of trans people suggest that factors related to mental health are 
associated with overall QoL [151]. The majority of studies addressing QoL among trans 
people focus on people who have undergone hormonal therapy or other gender-affirming 
healthcare interventions [137,152–155], in order to assess how these interventions improved 
QoL. A recently published meta-analysis found that, overall, trans people report poor QoL in 
all domains investigated, compared to the general population [154]. Another review assessing 
the QoL of trans people who received hormonal therapy and other gender-affirming therapies 
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found that 80% reported significant improvement in QoL after hormonal/medical 
interventions [137]. The positive effects of hormonal treatment on QoL was confirmed in 
another review [152]. A recent Swedish study which assessed QoL among trans women 
before and after gender-affirming surgery found that, overall, QoL improved one year after 
gender-affirming surgery [153]. The same study found that, while QoL improved, it was still 
lower compared to that of the general population [153]. Another study conducted among 
trans adolescents in Germany found that body dissatisfaction decreased QoL significantly as 
well as caused depression, anxiety and social withdrawal [155].   
 
Other studies have suggested that the QoL of trans people compared to that of controls or the 
general population, is similar, with some exceptions related to worse sexual functioning and 
mental health among trans people [156,157]. Most studies mentioned above, however, have 
in common that they exclusively included trans people with gender dysphoria, who had 
undergone gender-affirming interventions or who were in the process of doing so and hence 
did not include self-identified trans people who represent different gender-affirming 
healthcare needs. 
 
1.4.5 Sexual health and sexual satisfaction among trans people  
According to a review of the global burden of disease among trans people, sexual health is 
the second most researched area in this population (after mental health) [115]. The majority 
of studies concerning sexual health, however, are focused on sexual health risk outcomes 
[115].  
Trans women constitute a population which is disproportionately affected by alleviated rates 
of HIV  [158,159]. The reasons behind this high vulnerability are thought to be driven by 
multiple factors including biological aspects related to excess risk of HIV transmission as a 
result of receptive condomless anal intercourse, network-related determinants including high 
rates of HIV and lack of knowledge about HIV-status within trans women’s sexual networks, 
and structural determinants related to marginalization and discrimination of trans people. The 
latter determinants might limit the provision of important health and preventive services to 
trans people and might also lead some people to turn to sex work as a source of income [158]. 
Research also emphasizes how syndemic psychosocial health factors, such as depression, 
substance use, targeted victimization and internalized transphobia, may increase the risk of 
HIV and lead to worse HIV treatment outcomes [120,121]. Despite a large international body 
of research, the prevalence of HIV among trans people in Sweden is unknown.   
 
In recent years, quantitative and qualitative studies have focused on other aspects of sexual 
health such as body and sexual satisfaction [160], sexual activity and sexual abstinence 
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[160,161], the effect of gender dysphoria on sexual health [162] and perceptions of trans 
people about their sexual health [163].  
 
Trans people may face various challenges related to their sexual health. Fear of disclosing 
trans identity and fear of stigmatization and rejection in sexual contexts are some issues that 
affect the sexual health of many trans people [161]. It has also been indicated that trans 
people may feel objectified in some sexual situations, and treated with disrespect and 
prejudice in relationships due to their trans identity [161,163]. Studies suggest that gender 
dysphoria, body dissatisfaction and lack of access to treatment to ease this dysphoria may 
lead to sexual dissatisfaction [133,160,161,163]. Nikkeln et al. (2018) found that sexual 
feelings including sexual agency, sexual esteem and sexual pleasure were positively 
associated with body satisfaction [160]. Body dysphoria may also lead to trans people 
discovering their sexuality later in life [161,162]. Coping with body dysphoria may include 
imagining a different body, reinterpreting gendered body parts and by applying a gender role 
coherent with the gender identity in sexual situations [133]. Another strategy  reported in the 
literature to cope with the various sexual challenges that trans people might face is sexual 
abstinence and a “turning off” of one’s sexuality [133,161,162]. These challenges and 
strategies may affect sexual satisfaction among trans people.  
 
Another determinant of sexual health among trans people is hormone use. It is indicated that 
sexual desire increases among trans men who receive testosterone-derived hormones and to 
decrease among trans women due to use of estrogen-derived hormones [161,164]. One study 
did not find any relationship between sexual activity and hormone use, however, the authors 
suggested that this lack of association does not necessarily contradict effects on sexual desire 
[161].  
 
It is also suggested that aspects related to minority stress, i.e. being subjected to prejudice, 
discrimination and targeted victimization, are relevant aspects that negatively affect the 
sexual health of gender and sexual minorities [165]. Various studies report high rates of 
sexual violence among trans people [166–168]. Sexual violence affects sexual satisfaction in 
a negative way through affecting sexual activity, function, desire and pleasure [169]. Besides 
aspects which are trans-related and which may affect sexual satisfaction among trans people, 
common sexual health determinants are equally important for trans people. These factors 
include being generally satisfied, having a partner and absence of depressive symptoms, 
among others  [133,170]. 
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1.4.6 Medical and legal environment for trans people in Sweden  
1.4.6.1 Legal gender recognition  
Sweden was the first country in the world to allow change of legal gender in 1972 [132]. The 
same law also regulates permission to undergo gender-affirming genital surgery (but not 
other gender-affirming treatments) [132]. To change legal gender and to obtain permission 
for gender-affirming genital surgery, a person has to be at least 18 years of age and felt for a 
long time like they belonged to the other gender, have lived according to that corresponding 
gender role (so called real life experience) and are likely to keep on living according to that 
gender role [132].  
 
Up until 2013, legal gender recognition was possible if one was unmarried and a Swedish 
citizen [132]. Another requirement for legal gender recognition was that one had to undergo 
sterilization. This controversial requirement existed until 2013, when it was finally removed 
and people who apply for legal gender recognition are now offered fertility preservation prior 
to gender-affirming procedures [132]. In March 2018, the Swedish parliament took the 
decision to compensate trans people who had been forced to undergo sterilization between 
1972 and 2013. Approximately 600–700 people are eligible for this compensation of EUR 
22,500 [171]. Another change with regard to this regulation is that applicants no longer have 
to be unmarried or Swedish citizens. It is possible in Sweden to change legal gender to one of 
the two categories male or female [132].  
 
1.4.6.2 Anti-discriminatory regulations  
Other positive changes in recent years include the Discrimination Act (2008: 567) [172], 
which protects against discrimination in many areas, including healthcare, and which includes 
gender identity or expression as grounds for discrimination. In addition, the Government of 
Sweden has proposed legislative amendments that will enter into force the 1st of January 2019 
and would mean that trans people would be afforded full protection under the hate crime 
legislation [173].  
  
1.4.6.3 Gender-affirming healthcare in Sweden  
In Sweden, gender-affirming healthcare is covered by the national health insurance and 
includes cross-hormone treatment, masculinization/feminization surgery, voice therapy and 
hair removal. In order to access gender-affirming health care in Sweden, a referral from a 
general practitioner or a psychiatrist is most often needed [174]. Once referral has been 
attained, special multidisciplinary gender teams are responsible for the assessment and 
diagnosis of gender dysphoria. These specialists are also responsible for the referrals of 
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medical procedures and for providing an assessment for the Legal Gender Advisory Board 
[174]. The process of evaluation in these designated clinics includes physical, psychological, 
psychiatric and social assessments. This whole process from receiving the referral to 
provision of gender-affirming care could take around six months but due to long waiting lists, 
two to three years is not uncommon. People who want to change legal gender and undergo 
gender-affirming treatment need to fulfil the legal prerequisite of living according to the 
gender role corresponding to their gender identity, the so-called ‘real life experience’, for a 
period of 12 months [174]. The process from being referred to a gender team and to 
completed change of legal gender could take between two to five years. Although the 
Swedish healthcare system provides gender-affirming treatments and surgeries without out-
of-pocket expenditures, people who need access to these services often express frustration 
over the long waiting times and the long process that diagnosis and treatment entails. It is 
reported that these experiences of long waiting times to access trans-specific healthcare cause 
experiences of distress and anxiety [174].  
 
The national guidelines for the evaluation and treatment of gender-affirming care were 
revised in 2015 by the National Board of Health and Welfare in the report “Good care of 
adults with gender dysphoria” [175]. These guidelines adopted some improvements in 
comparison with previous guidelines. For example, since 2015, the evaluation process is 
more flexible and individualized [132]. Previously, only trans people who received the 
diagnosis “transsexualism” could receive gender-affirming healthcare [132]. Since 2015, 
however, trans people who do not necessarily fulfil the criteria for “transsexualism”, 
including gender non-binary people, are offered care. Additional changes in the 2015 
guidelines include: inclusion of some medical procedures that were previously excluded from 
the state funded care; and fertility preservation as an option prior to gender-affirming 
interventions [132].    
 
1.5 CONCEPTS AND THEORIES  
This thesis draws upon several concepts and theories, which are useful for understanding the 
complexity and interrelationships of factors that might affect health outcomes, including QoL 
and sexual satisfaction in the populations studied here. These theories were not necessarily 
used as an analytical tool in the individual studies, but elements of them were certainly used 
in the choice of variables to analyze and in interpreting our results as well as setting them in 
context. Below, the various concepts and theories relevant for this thesis have been listed.  
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1.5.1 Minority stress theory 
The minority stress theory originates in the work of John Meyer (2003) who sought to 
explain the excess burden of mental poor health among sexual minorities through a process of 
accumulated social stress [176]. Meyer’s theory extends on existing stress theories and argues 
that social stress is caused by conditions in the social environment as well as on a personal 
level. Meyer explains that people belonging to stigmatized social categories, including 
socioeconomic status, race, gender or sexuality, experience a strong impact of social stress. 
Minority stress refers to the social stress that stigmatized groups in society, often minority 
groups, experience: “The minority person is likely to be subject to such conflicts because 
dominant culture, social structures and norms do not typically reflect those of the minority 
groups” [176].  
 
A minority stress is characterized by several conditions. According to Meyer, minority stress 
is something that is unique, chronic and socially based. This means that the stressors 
experienced by minority groups are additive to the common stressors that affect everybody 
(i.e. unique). In addition, these stressors are chronic in that they are experienced on a regular 
basis. Finally, these stressors are caused by socially constructed differences and barriers, 
institutions and social structures and are not biological determinants [176].  
The minority stress model explains that minority stress occurs in a process of stress and 
stress-ameliorating factors on different levels:  
- Exposure to proximal and distal minority stressors: distal stressors are experiences of 
rejection and discrimination while proximal stressors refer to the stress caused by the 
internalization of rejection and stigma;  
- Stress-ameliorating factors: coping with and  adaption and resilience to stigma. Group 
identity and solidarity on an individual level and group-level social structures can also 
have a buffering effect on stress; 
- Stress and identity: group identities are essential for individual emotional 
functioning. The minority identity is something that could be emphasized and 
pointed out by others and cause distress to the individual who is identified as a 
minority. A minority identity is often also additive to other identities such as race 
and gender and these additive identities might cause aggregated stress.   
 
When first developed by Meyer, the minority stress model sought to explain health disparities 
in sexual minority groups. However, in recent years the model has been used to explain 
health disparities among other groups, including trans people and people living with HIV. 
Testa et al. (2015), for instance, have adopted the minority stress model to trans people by 
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adding/adjusting some important elements specific for trans people. For example, distal 
stressors that, in the original model, include discrimination and violence apply to trans people 
as well. However, trans people may face an additional distal stressor according to the authors, 
namely “non-affirmation”. Non-affirmation refers to the disagreement between an individual 
gender identity/gender presentation and how this gender is perceived by others.  The minority 
stress model has showed to be valid for explaining disparities in mental health inequalities 
among trans people [177].  
When applying the minority stress model to gay and bisexual men living with HIV, Rendina 
et al. [178] explain that “Similar to sexual minority stigma, HIV-related stigma operates 
through unjust social structures to negatively influence health. Similar to the evidence for 
sexual minority stigma, research shows that chronic exposure to HIV-related stigma 
might lead HIV-positive people to internalize negative messages about themselves and 
other HIV-positive individuals. Internalized HIV-related stigma has been associated with 
a range of negative mental health factors, including depressive symptoms, general 
psychological distress, low self-esteem, poor psychological well-being, and sexual 
compulsivity” [178].   
 
1.5.2  The socio-ecological model  
The socio-ecological model was proposed by McLeroy et al. [179] who described it as a 
model for health promotion. The model was developed to explain how, in order to promote 
good health and healthy behavior, one cannot only consider individual behavior, but the 
interaction between individual and social environmental factors is also important.  
The author explain that behavior is determined by multiple factors (Figure 2):  
- Intrapersonal factors are factors which are individual and include knowledge, 
skills and attitudes;  
- Interpersonal factors include the individual’s formal and informal relationships 
and their networks and social-support systems;  
- Institutional factors include social institutions and rules and regulations;  
- Community factors include relationship among organizations, institutions and 
informal networks within defined boundaries (including family and 
neighborhoods); 
- Public policy refers to local and national policies and legislation.  
Since it was developed in the late 1980s the socio-ecological model has been applied in 
understanding and conceptualizing various health and behavior aspects. It was applied in 
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physical activity behaviors [180], tobacco control research [180], to conceptualize HIV 
vulnerabilities [181] and sexual satisfaction [12], among others.  
 
 
Figure 2. The socio-ecological model  
1.6 RATIONELE FOR THE THESIS  
Research evidence from different countries indicate that overall QoL and sexual health of 
trans people and people living with HIV is multifactorial and is largely associated with social 
and structural factors. The vast majority of people living with HIV in Sweden are durably 
virally suppressed and are expected to live a long life. In addition, the legal environment is 
changing and progressing thanks to the favorable treatment conditions bringing with it new 
implications regarding the implementation of the Communicable Disease Act. For trans 
people, legal structures are in place to protect against discrimination and medical guidelines 
are progressing to meet an increasing requirement for the individualized care of trans people 
with diverse treatment needs. Yet, up-to-date research concerning QoL and sexual health 
among trans people [153,163] and people living with HIV [71,72,182–184] is scarce in 
Sweden. The sexual aspect of health that is addressed in this project is a response to an 
increasing need for a rights-based approach to sexual health which adopts the understanding 








  27 
2 AIMS AND OBJECTIVES  
The aim of this thesis was to explore quality of life (QoL) and sexual health as well as the 
associated factors thereof among trans people and people living with HIV. The overall goal 
was to identify needs and strategies that can enhance and support good living conditions 
among trans people and people living with HIV in Sweden today. 
The specific objectives were:  
 
I. To identify factors that are associated with QoL among people living with 
HIV 
II. To explore sexual satisfaction and its contributors among people living with 
HIV 
III. To examine factors associated with self-rated health and QoL in a population 
of self-identified trans people  
IV. To examine factors associated with sexual satisfaction in a population of self-
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3 METHODS  
3.1 SUMMARY OF STUDIES INCLUDED IN THE THESIS  
This thesis is based on two large surveys and cohorts: ‘Living with HIV’ was a nationwide 
survey conducted in 2014 and explored QoL in a representative population of people living 
with HIV (Paper I & II). ‘Health for all’ was a web-based survey conducted in 2015 and 
targeted people self-identifying as trans. The survey explored various aspects of health and 
QoL (Paper III & IV). Table 2 below illustrates the studies, study populations and data-
collection methods included in this thesis.  
Table 2. Summary of the papers included in the thesis  
Paper Study population  Research question Study design  Main analysis  




sexual, social support 
and personal 
components are 
associated with overall 
QoL among people 









II What factors are directly 
and indirectly associated 
with sexual satisfaction 





III Trans people 
(n=796) 
What factors are 
associated with the self-
rated, self-reported 
disability and QoL 
among self-identified 









i. What proximal and 
distal factors are 
associated with sexual 
satisfaction among self-
identified trans people in 
Sweden? 
ii. What characterize 
self-identified trans 
people’s sexual practice 
and needs for sexual 
health services? 
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3.2 LIVING WITH HIV (PAPER I & II) 
3.2.1 Survey development  
During 2013-2014, the Public Health Agency of Sweden financially supported a nation-wide 
study aiming to explore QoL among people living with HIV in Sweden. The study consisted 
of an anonymous, self-reported questionnaire. The questionnaire was developed and 
extensively piloted in close collaboration with healthcare partners and three large HIV-
organizations in Sweden: HIV-Sweden, Riksförbundet Noaks Ark (National HIV Association 
Noah’s Ark) and Stockholms Brukarförening (Stockholm’s Drug Users Union), in order to 
make the questions as relevant as possible. Participating clinics were invited to give feedback 
about the questions before the questionnaire was piloted (the questionnaire is available in a 
published report  [185]).  
 
3.2.2 Data collection procedures 
All 30 infectious disease clinics across the country were invited to participate in the data 
collection and 15 clinics agreed to do so. In addition, two needle exchange programs based in 
Stockholm participated in data collection (Appendix 1) in order to reach people who inject 
drugs. In total, 17 sites participated in the data collection, representing 75% of all (at the time 
of data-collection) known HIV patients in the country. The desired sample size was 
calculated previous to data collection based on the national quality HIV-care registry InfCare 
HIV, where all known people living with HIV are registered [15]. It was decided to target 
15–20% of the total number of patients with HIV at each data-collection site/clinic. A 
consecutive recruitment of people living with HIV was conducted by offering the 
questionnaire to patients visiting their assigned healthcare facility for a routine visit during 
the data collection period (December 2013-August 2014) excluding patients <18 years of age 
and who were newly diagnosed (<6 months prior to the study).  
 
Eligible patients visiting their designated clinics for routine visits were asked by the study’s 
different contact persons (nurses, doctors and counsellors) at each clinic if they wanted to 
participate in the study. In addition, information about the study was distributed through the 
collaborating HIV-organizations, through posters at infectious disease clinics across the 
country (Figure 3) as well as on the study’s website (www.attlevamedhiv.se) which informed 
about the survey in the different languages the survey was available in (specified below, 
under ‘Survey administration’). At two infectious disease clinics in Stockholm (Huddinge 
and Venhälsan), that together account for >60% of the proportion of outpatients across the 
country, a group of three research assistants were on-site during designated times during the 
weeks of data-collection, in order to recruit patients. To monitor data collection progress, one 
research assistant was designated to have oversight of all data-collection sites across the 
country.  
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In order to ensure the recruitment of a valid study population, contact persons at each site 
were asked to keep a log of the number of people who were asked to participate and who 
agreed and declined participation based on gender, approximate age, born in Sweden/ abroad 
and assumed route of transmission for each participant/non-participant. For various reasons, 
including limited time for the health workers/contact persons to fill in the reports, and 
hesitation about filling in the logs without revealing identifying details that could jeopardize 
patient integrity and confidentiality, log lists on participants/non-participants were filled in 
inconsistently (see also “Methodological discussion”). While some data collection sites had 
regularly kept log lists about outpatient participations, other sites sent incomplete lists. These 
inconsistencies undermined our ability to conduct a non-response bias analysis and to 
estimate the response rate. However, thanks to the national quality registry system of all 
people living with HIV in Sweden, InfCare HIV, we can estimate the rates of participation 
according to some sociodemographic characteristics (i.e. sex, age, mode of HIV transmission, 
and country of birth). From the sites that had consistently filled in the log lists, the 
participation rate was 70%. These sites however are not representative of the whole country 
since they are located in smaller counties with fewer patients. At other sites, the participation 
rate varied from 37% (Huddinge, Karolinska University Hospital the largest data collection 
site) to 57% (Skåne University Hospital, Malmö, the third largest data collection site). Some 
trends could be identified from the log list reports: women, more often than men, declined 
participation or did not send the completed questionnaire after agreeing to participate. In 
addition, people born outside Sweden and whose mode of HIV transmission was heterosexual 
sex seemed to be less likely to participate compared to Swedish-born non-heterosexuals.  
 
 
Figure 3. The “Living with HIV” survey’s logo 
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3.2.3 Survey administration 
The final questionnaire included 77 items. The questionnaire covered information on 
sociodemographic characteristics, HIV-related physical, psychological and sexual aspects, 
getting older with HIV, being able to travel, satisfaction with HIV care, social support and 
quality of life. To reduce the risk of underrepresentation of migrants, the questionnaire was 
made available in 10 languages: Swedish, English, French, Spanish, Russian, Thai, Somali, 
Amharic, Arabic, and Tigrinya. Those who could not fill out the questionnaire in any of the 
languages or those with reading and writing difficulties who wanted to participate were 
offered to have the questions read to them by a telephone interpreter in a confidential setting 
at the respective collaborating infectious disease outpatient clinic. However, none of the 
participants chose this service. 
 
 During the recruitment period, outpatients living with HIV visiting their infectious disease 
clinics were informed about the study and invited by a site coordinator to anonymously 
participate in the study by completing a questionnaire in their language of choice. Participants 
in the study were not offered any compensation but the purpose and the importance of the 
study were explained to them. Participants could complete the questionnaire in a confidential 
setting at their outpatient clinic, put the questionnaire in a sealed envelope, and drop it in a 
locked box. Alternatively, participants could choose to complete the questionnaire at home 
and mail it in a pre-stamped envelope to the research team at Karolinska Institutet (for 
information given to participants, see Appendix 2). The site coordinator collected the sealed 
envelopes and sent them to the research team at the Karolinska Institutet. Completion of the 
questionnaire took between 20 and 40 minutes. 
 
3.2.4 Dependent variables  
In Paper I, QoL was assessed by a single item, asking participants to rate their QoL on a 
visual analogue scale (VAS) ranging from 0 (very poor QoL) to 10 (very good QoL). For 
analyses, the variable QoL was used as an ordinal variable with 11 categories.  
 
In Paper II, to assess sexual satisfaction, one item from the Life Satisfaction checklist 
(LiSAT) was used [186]. Participants were asked to rate their level of satisfaction with their 
sex life with the help of a six-point scale. The question was formulated as follows: “With my 
sex life I am… ..’’(‘‘very dissatisfied’’, “dissatisfied”, “rather dissatisfied”, “rather satisfied”, 
“satisfied”, ‘‘very satisfied’’). We chose a cut-off at ‘‘rather dissatisfied’’, which was coded 
as dissatisfied. The sexual satisfaction scale was thus dichotomized (satisfied/dissatisfied) for 
analyses.  
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3.2.5 Study respondents  
In total 1,100 people responded to the survey “Living with HIV”. However, not all 
respondents were included in the respective analyses in Paper I and Paper II. Four 
respondents (n=4) were removed from further analyses based on them not meeting the 
inclusion criteria (having received their HIV diagnosis <6 months prior to recruitment). After 
removal of these respondents, the total number of respondents was 1,096. In Paper I, we 
excluded 10 respondents who did not report their gender, leaving a study population of 1,086 
respondents. In Paper II, 14 respondents were excluded from analyses. Since the analysis of 
sexual satisfaction was gender-dependent, respondents who did not report their gender (n=10) 
and who reported “other” gender identity (n=4) were removed from analyses.  
 
3.2.6 Statistical analysis  
In Paper I, we identified contributors associated with self-reported QoL by employing 
descriptive statistics, univariate and multivariate ordinal logistic regression analysis. 
Significant (p ≤ .05) variables from univariate analyses and other considered important 
control covariates (gender, age, birth origin, level of education, sexual orientation and time 
since HIV diagnosis) were later included in a multivariate ordinal logistic regression analysis. 
The measures of association are presented as crude and adjusted odds ratios (OR/aOR), with 
95% confidence intervals (CI). A non-response or the response “do not want to answer” on 
considered sensitive items, such as sexual orientation, HIV transmission route and injecting 
drug use, were coded as ‘missing/do not want to answer’. Otherwise, to manage missing data, 
we conducted multiple imputation using chained equations [187]. For the estimation of the 
analysis, twenty imputed datasets were used. In the imputation modelling, logistic regression 
was used for the binary variables, ordinal logistic regression for the ordinal variables, 
multinomial logistic regression for the nominal variables, and linear regression for the 
continuous variable. The dependent variable was also included in the imputation modelling, 
but excluding observations with missing values [188]. Stata version 13.1 (StataCorp LLC, 
College Station, TX) was used for all analyses in Paper I.  
 
In Paper II, we investigated direct and indirect paths of associations between various 
variables and sexual satisfaction by applying a path analysis. The analyses included four 
stages. First, we analyzed the data descriptively. Secondly, we conducted univariate analyses 
of covariates of interest (Table 3) and the outcome sexual satisfaction and identified 
significant variables. Significant variables from univariate analyses (p ≤ .05) were then 
included in multivariate logistic regression. In the third stage, in order to assess potential, 
indirect contributors to sexual satisfaction, each significant variable from the previous stage 
(multivariate analysis) was treated as a dependent variable and all covariates from the first 
stage (univariate analysis) as independent variables. We applied univariate logistic regression 
for categorical variables and univariate linear regression for continuous variables. Significant 
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independent variables from univariate analyses were then included in multivariate linear or 
logistic regression models. All analyses of male participants were adjusted by self-reported 
sexual orientation. In addition, for all univariate and multiple analyses with categorical 
outcomes, we calculated OR and 95% CI. The last stage of analysis included fitting two path 
models, one for male participants and one for female participants and evaluation of direct and 
indirect paths between covariates and sexual satisfaction. To estimate model fit, full models 
were compared to null models using the likelihood difference test, where -2 times the log 
likelihood difference is distributed as chi-square (Browne &, Cudeck, 1993), and differences 
in Akaike Information Criteria (AIC) and Bayesian Information Criteria (BIC).  
 
To manage missing data, we conducted multiple imputation. Imputation for variables with 
missing values was conducted using Bayesian analyses [190]. Ten imputed datasets were 
used in the estimation of all analyses using maximum likelihood estimation. Maximum 
likelihood parameter estimates for each analysis were averaged over the set of 10 analyses 
and standard errors were computed using the average of the standard errors of the analyses 
and the between analyses parameter estimation. The statistical analyses were performed with 
MPlus version 7.4 [191].   
 
In both studies (Paper I & II), independents variables were clustered into components. In 
Paper I, independent variables were grouped into sociodemographic, behavioral, clinical, 
psychological, sexual life, social support and personal resource components. In study II, 
independent variables included in the analyses were clustered into four components: the 
sociodemographic, the clinical HIV-related, the psychological, and the sexual component. 
Analyzed covariates were coded differently depending on the statistical analysis performed. 
In Paper I, covariates were mostly categorical while in Paper II they were dichotomous.   
Table 3 below illustrates the independent variables from Paper I &II, how they overlap and 
how they differ. 
 
Table 3. Covariates included in Paper I and Paper II  
Variable 










Gender   the alternative “other” in Paper I was kept despite 
few observations 
Male Male  
Female Female  
Other -   
Age (years)   
Birth origin   
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Sweden  Sweden   
Outside Sweden  Outside Sweden   
Employment   Dichotomised from originally ‘choose all that 
apply’-item with 15 alternatives listing different 
occupations 
Working/studying Working/studying  
Unemployed/long-term 




Education  Condensed into fewer categories from originally 
six alternatives representing length of education in 
years   
0–9 years   -   
10–12 years  <12 years  
>12 years  >13 years  
Monthly income -  Dichotomised from seven self-reported income 
alternatives  
Middle/high-income   
Lower income    
Sexual orientation   Condensed into fewer categories from originally 
five alternatives. In Paper I, we kept the missing 
observations and the response alternative “Do not 
want to answer”  
Heterosexual  Heterosexual   
Non-heterosexual  Non-heterosexual   
 Do not want to 
answer/missing 
-   
Relationship status    
Partner  Partner   
No partner  No partner   
Homelessness past 6 
months 
-   
Smoking -   
Non-smoker    
Former smoker    
Current smoker    
Drug use past 6 months  -   
No drug use    
Drug use    
Do not want to 
answer/missing  
  
Alcohol consumption -  Variable is based on three items summed into a 
scale, analysed according to the Alcohol Use 




Hazardous consumption    
Clinical component   
Time since HIV 
diagnosis   
  
< 1–5 years  -  Condensed into fewer categories from originally 
six response alternatives representing time since 
diagnosis  
5–10 years  <10 years   
> 10 years >10 years   
Mode of HIV 
transmission  
-  In Paper I, we kept the missing observations and 
the response alternative “Do not want to answer” 
Heterosexual contact    
Sex between men    





Blood   
Other      
Missing/do not want to 
answer  
-   
Comorbidities  -  Dichotomised based on reporting one or more of 
seven disease alternatives or stating “no” on an 
item about co-diseases  
Yes   
No   
HIV-related physical 
symptoms 
-   
Yes   
No   
Don’t know   
Side-effects from ART  In Paper I the variable is based on two items 
concerning: (1) experiencing of side-effects from 
ART and (2) whether one is bothered by these 
side-effects. In Paper II the variable is only based 
on the first question 
Yes  Yes  
No No  
Psychological component   
Hopelessness   The variable is analysed using the Beck 
Hopelessness Scale [193]  which includes 20 
true/false statements 
Absent  Absent   
Mild -   
Moderate-severe Mild-moderate-severe  
HIV-related stigma   The variables were analysed using 12 items based 
on the 12 items Swedish short-form version [194] 
of the HIV Stigma Scale [78]. The instrument 
produces three sub-scales. In Paper I, each stigma 
variable was divided to 3 categories representing 
different levels of stigma while in Paper II, only 
two dimensions (sub-scales) of stigma were 
analysed and each sub-scale was dichotomised.  
Personalised stigma  -   
Lower stigma    
Fairly high stigma    
Higher Stigma    
Negative self-image    
Lower stigma  Lower stigma   
Fairly high stigma  -    
Higher Stigma  Higher Stigma   
Concerns with public 
attitudes  
  
Lower stigma  Lower stigma   
Fairly high stigma  -    
Higher Stigma  Higher Stigma   
Disclosure concerns -   
Lower stigma    
Fairly high stigma     
Higher Stigma    
Satisfaction with HIV 
disclosure  
-   
Satisfied   
Would like to be more 
open 
  
Would like to be less open   
Do not want to answer    
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-  HIV-related PTSD 
symptoms 
Variable is based on 15 items composing the 
Impact of Event Scale [195] 
 Absent   
 present  
Sex-life component    
Sexual satisfaction   One item from the Life Satisfaction checklist 
[186]. In Paper I, sexual satisfaction is an 
independent variable and in Paper II the 
dependent variable 
Satisfied Satisfied  
Dissatisfied  Dissatisfied   
Changes in sex life due 
to HIV 
 In Paper I, we kept the missing observations and 
the response alternative “Too personal/cannot 
decide” 
No change No change  
Positive change Positive change  
Negative change Negative change   
Too personal/cannot 
decide   
-   
-  Sex in the past 6 months  
 Yes  
 No  
-  
 
Importance of sex Dichotomised from originally four response 
alternatives  
 Very or fairly important  
 Not very important or not 
important at all 
 
-  Sexual desire in the past 6 
months 
Dichotomised from originally four response 
alternatives 
-  Yes  
-  No  
-  Sexual pleasure in the past 
6 months 
Dichotomised from originally four response 
alternatives 
-  Yes  
-  No  
-  For male respondents: 
Erectile difficulties  
Dichotomised from originally five response 
alternatives 
 Never or rarely  
 Sometimes, often or always  
-  For male respondents: 
Distress due to erectile 
difficulties 
 
 No distress  
 Minor or major distress  
-  For female respondents: 
Orgasmic difficulties 
Dichotomised from originally five response 
alternatives 
 Never or rarely  
 Sometimes, often or always  
-  For female respondents: 
Distress due to orgasmic 
difficulties 
Dichotomised from originally three response 
alternatives 
 No distress  
 Minor or major distress  
-  For male respondents: 
Ejaculatory difficulties  
Dichotomised from originally five response 
alternatives 
 Never or rarely  
 Sometimes, often or always  
-  For male respondents: 
Distress due to ejaculatory 
difficulties 
Dichotomised from originally three response 
alternatives 
 No distress  
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 Minor or major distress  
 Obligation to disclose HIV 
status an obstacle to look 
for a long-term partner 
Dichotomised from originally three response 
alternatives 
-  Definitely or to a certain 
extent 
 
 Not at all  
Social support component  -   
HIV-related support    Dichotomised from originally six response 
alternatives 
Have HIV-related support    





-   
Change in perceived 
self-esteem due to HIV 
  
No change    
Positive change   
Negative change    
Meaningful life after 
HIV diagnosis 
  
Life is as meaningful   
Life is more meaningful   
Life is less meaningful   
 
3.3  HEALTH FOR ALL (PAPER III & IV)  
3.3.1 Survey development 
During the autumn of 2014, the Public Health Agency of Sweden initiated a study exploring 
the health situation and health determinants of trans people. This study was commissioned as 
a part of the Public Health Agency’s mandate to analyze health and health determinants 
routinely among lesbian, gay, bisexual, trans and queer (LGBTQ) persons [196].  
 
The survey was developed by researchers at Karolinska Institutet in collaboration with the 
Public Health Agency of Sweden, the Swedish Federation for Lesbian, Gay, Bisexual, Trans 
and Queer (LGBTQ) Rights (RFSL) and the Swedish Youth Federation for LGBTQ Rights 
(RFSL Ungdom). In addition, several expert group meetings took place with trans people, 
trans organizations, with specialists working clinically with trans people and with different 
governmental agency who in different ways work with relevant trans-related topics. These 
meetings were organized not only for the development of the questionnaire but also for 
consultation about the dissemination of results once data was collected.  
 
The final survey was administrated on the web and included 106 questions (including skip 
questions) covering eight main themes; sociodemographic background, general health, 
wellbeing, gender-affirming treatment, life-style habits, experience of victimization and 
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social support networks, sexual life and QoL. It took between 20-40 minutes to complete. 
The survey included some questions previously included in Swedish population health 
studies for comparison purposes. Trans-specific questions were developed by the research 
team or were partly based on surveys conducted in other countries (the questionnaire is 
available in a published report [196]). The survey was pilot-tested with six trans-identified 
individuals and revised accordingly before being finalized.  
 
3.3.2 Data collection procedures  
Data was collected via an anonymous, self-selected web-based survey, carried out between 
September and November 2014. Convenience sampling was used to recruit participants since 
the trans population is of an unknown size and hard to reach via means of random sampling. 
In this study, participants were recruited through email invitations by Scandinavia’s largest 
online community for LGBTQ people, Qruiser (https://www.qruiser.com), as well as by 
advertisements on the same website. Qruiser sent reminders to trans members who did not 
open the link to the survey one week after the first message was sent out. Other large LGBTQ 
organizations promoted the study via different social media channels and personal invitations. 
In addition, clinics specializing in gender-affirming related care received information about 
the study and were encouraged to inform their patients. Advertisements about the survey 
were also made online, via Google AdWords. Individuals aged >16, who live in Sweden, 
speak Swedish and identified as being or ever being trans were eligible to participate in the 
study.  
 
Data collection was regularly monitored and reported to the research team in order to 
optimize the number of responses and the channels of recruitment. Since there was no pre-
determined sample size, it was decided to set a date for the last day of data collection which 
was the end of October 2014 (two months in total). Our guiding assumptions about optimal 
sample size were made according to previously conducted studies with similar methodology 
which reached 300-400 respondents [197,198], and our goal was therefore to reach 
approximately 400 respondents by the end of data collection. Oversight of data collection 
included daily monitoring of the link to the web-survey to make sure there were no technical 
issues, registering the number of daily respondents to the web-survey and contacting 
collaborating organizations about sending reminders and messages about the survey.  
 
3.3.3 Survey administration  
The survey was administrated online, via an URL link that was distributed via various online 
channels (described above, under ‘Data collection procedures’). The survey was constructed 
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using LimeSurvey, which is electronic web-survey software. In order to complete the survey, 
respondents were asked to click “I agree” on an electronic consent form (Appendix 3). 
 
3.3.4 Dependent variables   
Dependent variables in Paper III were QoL, self-rated health and self-reported disability. QoL 
was assessed, similarly to Paper I, using a single question asking participants to rate their 
QoL on a visual analogue scale ranging from 0 (very poor QoL) to 10 (very good QoL). For 
the purpose of analysis, we dichotomized the outcome QoL by making an arbitrary cut-off at 
the median score of the scale (=6).  
Self-rated health was measured by the question: “How would you assess your general 
health?” The variable was categorized into good (“very good” and “good”), fair self-rated 
health (“fair”) and poor (“poor” and “very poor”).  
Self-reported disability was defined by the answers: (1) “Yes, to some extent” or, (2) “Yes, to 
a high extent” to the question “Do you have any physical or mental condition that impairs 
your work ability or hinders you in your everyday life?”  
Sexual satisfaction, the dependent variable in Study IV, was assessed using the same 
instrument, LiSAT, as in Paper II (see above) [186].  We chose a cut-off at ‘‘rather 
dissatisfied” and coded that response as “dissatisfied”.’’ The sexual satisfaction scale was 
thus dichotomized (satisfied/dissatisfied) for analyses. 
 
3.3.5 Study respondents  
In total, 796 eligible respondents completed the survey included in Paper III and IV. In Paper 
III, all 796 respondents were included in the analysis. In Paper IV, however, the analysis is 
based on 595 respondents. Participants who had never had sex were removed from the 
analysis (n=76), in addition to respondents who did not complete the voluntary section of the 
questionnaire concerning gender-affirming healthcare (n=110). Fourteen more individuals 
were excluded due to missing values on the selected variables. 
 
3.3.6 Statistical analysis   
In Paper III, descriptive analyses (frequencies) were carried out to describe the characteristics 
of study participants and univariate and multivariate analyses were performed for each 
respective health outcome (i.e. self-rated health, self-reported disability and quality of life) for 
all variables of interest. For the outcome self-rated health, ordinal logistic regression was 
used and for the outcomes quality of life and self-reported disability, logistic regression was 
used. The measures of association are presented as crude and adjusted OR, with 95 % CI. 
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Three backward selection models were performed, one for each health outcome, in order to 
identify significant variables for each respective outcome. A Wald’s test was used for 
variables with more than one category in univariate and multivariable analyses, in order to 
assess significance of the variable as a whole. Stata, version 13.1 (StataCorp LLC, College 
Station, TX) was used for all analyses in Paper III.  
 
In Paper IV, descriptive analyses were performed by computing frequencies of target 
variables. In order to assess multicollinearity, variance inflation factors (VIF) and a tolerance 
test were executed by examining all the variables of interests. Multicollinearity was not 
identified in the data judging from VIF values of below 4.0 and a tolerance level of less than 
0.2 [199]. Logistic univariate regression analyses were performed between the dependent 
variable sexual satisfaction and each of the explanatory variables listed below (Table 4). 
Variables with a p-value <0.2 in the univariate analyses and those considered to be relevant 
(sexual violence) were later included in the multivariate logistic regression analysis. 
Variables with a p-value <0.05 were considered statistically significant in multivariate 
analysis. The measures of association are presented as crude and adjusted OR, with 95% CIs. 
All analyses in study IV were executed using Stata version 15.1 (StataCorp LLC, College 
Station, TX).  
The independent variables included in Paper III and IV are detailed in Table 4.  






Outcome: sexual satisfaction  
Coding method/comment  
Trans experience   Variable composed of two items 
regarding gender identity and trans 
experience. In Paper III we use the 
self-identified term “transvestite” and 
in Paper IV we use the term “cross-
dresser” 
Trans feminine  Trans feminine   
Trans masculine Trans masculine  
Gender non-binary  Gender non-binary   
Transvestite  Crossdresser  
-  Sexual orientation  Variable dichotomised from 
originally nine alternatives and 
composed of “check-all –that- apply” 
question  
 Homosexual/heterosexual/asexual  
 Other  
Age (categories) Age (years)  
16–19   
20–29   
30–44   
45–64   
65–94    
Country of birth  -   
Sweden    
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Other than Sweden    
County  -  Dichotomised from 21 response 
categories listing the different 
Swedish counties 
Large county (< 500,000 
inhabitants)  
  
Small county (> 500,000 
inhabitants) 
  
Employment status  -  Dichotomised from originally 
‘choose all that apply’-item with nine 
alternatives describing different 
occupations 




Retired     
Other    
Education -  Condensed from originally eight 
alternatives representing different 
types of education 
No high school education   
Upper-secondary education, or 
some university 
  
University education ≥ 3 years   
Other    
Monthly net income (€) -   
0–1416   
1417–2125   
2126–3238   
>3239   
Tobacco use ever  -  Originates from two items about the 
use of snuff or cigarette smoking. 
Used to (smoke or use snuff) but 
quit, is coded as ‘yes’.  
Yes    
No   
Alcohol risk consumption  -  Based on one item about the number 
of drinks consumed on a typical 
drinking session. ≥ 5 drinks was 
considered risk consumption  
Yes   
No   
Illicit drug use (6 months) -   
Yes   
No   
Do not want to answer    
Religiosity  -  Dichotomised from originally four 
response alternatives  
Yes   
No   
Self-rated health  The variable self-rated health was a 
dependent variable in Paper III and 
an independent variable in Paper IV 
Good Good  
Fair Fair  
Poor Poor  
-  Negative mood symptoms Condensed from originally five 
response alternatives concerning how 
often one had felt unhappy during the 
past weeks  
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 Yes  
 Sometimes   
 No  
-  Offensive treatment  Based on two items on (1) experience 
of offensive treatment in the past 12 
months, and (2) the reasons for being 
offended. If the reasons included 
‘gender’ or ‘gender 
identity/expression’, variable was 
coded as ‘yes’  
 Yes  
 No  
-  Sexual violence  
 Yes  
 No  
Gender legal recognition     
No, and do not need to  No, and do not need to   
Yes Yes  
No, but would like to  No, but would like to   
No, and cannot change legal 
gender because the 
desired gender is not available 
in Sweden today 
No, and cannot change legal 
gender because the 
desired gender is not available in 
Sweden today 
 
Do not want to answer  -   
-  Need for gender-affirming 
healthcare 
assessed by two questions: (1) ‘‘have 
you ever sought professional help to 
get a referral to gender-affirming 
healthcare?’’ ,and: (2) ‘‘have you 
ever received a referral to gender-
affirming healthcare?’’  
 No need   
 Need unfulfilled   
 Need (partly) fulfilled   
-  Hormone use Analysed as an interaction term 
together with the variable ‘sex 
assigned at birth’  
 Yes  
 No  
-  Living according to gender 
identity  
Dichotomised from originally four 
response alternatives 
 Yes  
 No   
Openness with trans identity  -   
Always open    
Sometimes open    
Rarely open    
Never open    
Trans identity shows    
History of negative health 
care experiences  
-  dichotomised from multiple 
responses to the question: 
“Have you experienced any/some of 
the following events when you 
encountered the health care system?” 
Yes   
No   
Practical support  -   
Always    
Most of the time    
Almost never    
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Never    
Social support    
Yes  Yes   
No  No   
-  Number of sexual partners last 
12 months 
 
-   Current sexual partner   
 Yes, one  
 Yes, several  
 No  
-  Relationship satisfaction  
 Satisfied   
 Dissatisfied   
 Have no relationship/missing  
-  History of sex in exchange for 
money 
Dichotomised from originally four 
response alternatives 
 Yes  
 No  
-  Possibilities to discuss sexual 
matters with healthcare 
Condensed from originally six 
response categories  
 Yes  
 Doubtful  
 No  
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4 ETHICAL CONSIDERATIONS  
4.1 ETHICAL PERMITS  
Both studies included in this thesis had ethical permits. The study ‘Living with HIV’ (Paper I 
& II) was approved by the Reginal Review Board in Stockholm (DNR 2013/1552-31/4) and 
the study ‘Health for all’ (Paper III & IV) was approved by the Reginal Review Board in 
Stockholm (DNR 2014/857-31/5).  
 
4.2 INFORMED CONSENT  
Informed consent was obtained for both studies:  
In the study ‘Living with HIV’ (Paper I & II), participants received written information about 
the study, including information about the nature of the questions and the fact that 
participation in the study was anonymous and voluntary (Appendix 2). At the end of the 
information text provided in the questionnaire, participants were informed that by responding 
to the questions, they were consenting to participation.  
 
In the study ‘Health for all’ (Paper III & IV), which took the form of a web-based survey, 
participants received information about the study electronically, when clicking on the link to 
the web-survey. The electronical information page explained the purposes of the study and 
who participants could contact in case of questions and where they could turn to if they 
needed support. Participants were also informed that their participation was voluntary and 
anonymous. At the end of the information page, participants were asked to give their consent 
by clicking “I agree” to the statement: “I have received written information about the study 
‘Health and life situation for transgender people in Sweden’ and agree to participate in the 
study. I know my involvement is voluntarily and that my answers are completely 
anonymous” (Appendix 3).  
 
4.3 PRIVACY AND CONFIDENTIALITY  
Data collection procedures were completely anonymous and there is no risk for identification 
of individuals in the way data is presented. For Paper I & II, participants could answer the 
questionnaire in the privacy of their home and send their completed questionnaire by pre-
stamped post or by sitting in a quiet and private space in the clinic which they were visiting. 
Despite anonymity and flexibility as to where to fill in the questionnaire, many respondents 
chose to complete the questionnaire in Swedish and not in their mother tongue (Table 5) and 
none of the respondents used the services of a translator. In addition, nearly 13% did not 
report their country of birth, which implies that some participants did not fully trust that their 
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answers were completely anonymous and our general impression was that reluctance to 
reveal country of birth/choose questionnaire in the mother tongue was related to stigma and 
fear of being identified. For Paper III & IV, the survey was completed online and there was 
no interaction between participants and data collectors. Participants could answer the 
questionnaire on their computers and in their own time.  
 
Table 5. Proportion of questionnaires taken in the different languages offered (Paper I & II) 
Language  n (%)  
Amharic  12 (1) 
Arabic 8 (1) 
English 86 (8) 
French 18 (2)  
Russian  8 (1) 
Somali  4 (0.3) 
Spanish 9 (1) 
Swedish 895 (82) 
Thai 40 (4) 
Tigrinya  16 (1) 
Total 1,096 (100) 
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5 MY ROLE IN THE PROJECTS’ DIFFERENT PARTS  
5.1 DATA COLLECTION, DATA ANALYSIS AND RESULTS DISSEMINATION 
PAPER I & II  
I became involved in the project ‘Living with HIV’ (Paper I and II) from the early phases of 
data collection. I joined the project as a research assistant and my role was to, together with 
two research assistants, recruit patients visiting the infectious disease clinic in Huddinge 
(Karolinska University Hospital) and to have oversight of the collected questionnaires from 
the different data-collection sites. At a later stage, I was also responsible, together with 
another research assistant, for data entry from all surveys. I was thus familiar with the data 
from the early stages of data collection and my interaction with patients at the clinic also 
made me aware of different aspects of the data collection procedures.  
 
I executed the preliminary data analysis including data cleaning and coding. Main data 
analysis was mostly conducted by a statistician (Jonas Höijer), however I was involved in all 
stages of data analyses from data preparation to planning and executing the analyses. For 
study II, where I am the second author, the main data analysis was conducted by a statistician 
and by the first author, Lena Nilsson Schönnesson. My involvement included, in addition to 
preliminary data analysis, the interpretation of results and drafting of the manuscript. 
Naturally, I was also heavily involved in manuscript preparations from the derived data. In 
Paper I, I was the corresponding author and in Paper II, I was heavily involved in manuscript 
preparations and editing.  
 
The results of the studies, in particular of study I, were disseminated by me to various 
stakeholders and in different contexts in order to make better sense of the results and set them 
in context, both for HIV-organizations and for researchers and healthcare providers working 
with people living with HIV.  In addition, I presented the results from the project in 
international conferences and educational purposes.  
 
5.2 DATA COLLECTION, DATA ANALYSIS AND DISSEMINATION OF 
RESULTS PAPER III & IV 
I was hired as a research assistant at Karolinska Institutet to coordinate the project ‘Health for 
all’ in 2014–2015. Because of my early involvement in the project, I was able to contribute to 
all the different stages of its progress: I drafted the ethical application, developed the 
questionnaire in collaboration with a team of experts, was responsible for pilot-testing the 
questionnaire and executing the data-collection procedures. The process of developing the 
survey included continuous communication and various meetings and collaborations with 
 48 
expert organizations, the Public Health Agency of Sweden, healthcare providers and 
researchers. I also bore the main responsibility for this communication.  
With regard to data analyses, I performed the preliminary data analysis including data 
cleaning and coding. In Paper III, a statistician conducted the main analysis in close 
collaboration with me while I conducted all the analyses in Paper IV.  
I am the corresponding first author in the publications that are derived from this project 
(Paper III and another published paper which is not a part of this thesis [123]), as well as the 
corresponding first author on the manuscript included in this thesis (Paper IV).  
I also disseminated the results from the various studied included in this project at 
international conferences, in government agencies and in educational contexts.  
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6 RESULTS  
6.1 QUALITY OF LIFE AMONG PEOPLE LIVING WITH HIV (PAPER I)  
6.1.1 Respondents characteristics 
In total, 1,086 respondent were included in the analysis. Table 6 details the descriptive data 
on the sociodemographic and HIV-related characteristics of the study respondents. The 
majority of respondents were men (70%), 29% were women and 1% reported another gender 
identity (and were included in the analysis, despite few observations). The age range was 18–
82 with a mean age of 47.6 years and 41% were born outside Sweden. Nearly half (47%) had 
higher education (>12 years) while 19% had not completed secondary education and over 
one-half (55%) had a low monthly income. The majority worked or studied (75%), 43% were 
non-heterosexual and 57% had a partner. The most common mode of HIV transmission was 
sex between men (41%), followed by heterosexual sex (32%) and injecting drug use (11%). 
Nearly half (48%) had been living with HIV for >10 years, and 95% were on ART.  
 
Table 6. Characteristics of respondents in Paper I & II (n=1096) 
Variable  n (%) 
Gender   
Men 762 (70) 
Women 320 (29) 
Other  4 (0.3) 
Age   
< 30 71 (7) 
31–40  226 (22) 
41–50  341 (33) 
51–60  238 (23) 
61–70  125 (12) 
> 71 25 (2)  
Birth origin   
Sweden/Scandinavia  636 (59) 
Outside Sweden/ Scandinavia 433 (41)  
Region of birth  
Sweden/Scandinavia  641 (59) 
Africa 176 (16) 
Not specified  148 (14) 
Asia  57 (5) 
Other European countries 46 (4) 
Latin America 28 (2) 
City/county   
Stockholm/Malmö/Gothenburg  782 (73) 
Another large city 75 (7) 
Smaller city 127 (12) 
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Rural area  73 (7) 
Do not want to answer  13 (1) 
Employment   
Working/studying 724 (75) 
Unemployed/long-term sick leave  246 (25) 
Education  
0–9 years  206 (19) 
10–12 years  361 (34) 
  >12 years  494 (47)  
Monthly income   
Middle/high-income 451 (45) 
Lower income  545 (55) 
Sexual orientation   
Heterosexual  477 (44) 
Non-heterosexual 468 (43)  
Missing/do not want to answer  141 (13) 
Relationship status  
Partner  611 (57) 
No partner  462 (43) 
Homeless past 6 months (Yes) 73 (7) 
Time since HIV diagnosis   
 0.5–5 years  47 (4) 
5–10 years  500 (47) 
> 10 years 513 (48) 
Mode of HIV transmission   
Heterosexual sexual contact  352 (32) 
Sex between men  440 (41) 
Injecting drug use  115 (11) 
Mother-to-child transmission 13 (1) 
Blood 39 (4) 
Other  70 (6)  
Missing/do not want to answer  57 (5) 
On ART  
Yes 1037 (96) 
No 42 (4) 
 
6.1.2 Factors associated with quality of life among people living with HIV   
The majority of respondents, 66%, reported QoL scores ranging from 7 to10 on a 0–10 scale, 
where 0 is the lowest possible QoL and 10 is the highest possible QoL. In the multivariate 
regression analysis, self-reported QoL was not associated with gender, sexual orientation or 
country of birth. Below, I present the results by reporting on the significant contributors (p ≤ 
.05) of QoL in the multivariate regression analysis, per component of analysis.   
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6.1.2.1 Sociodemographic and behavioral component  
Socio-behavioral variables associated with QoL among people living with HIV included 
recent homelessness (aOR: 0.52; CI: 0.30-0.90) and hazardous alcohol consumption (aOR: 
0.71; CI: 0.53-0.97). Income, level of education, employment and relationship status were not 
found to be associated with QoL.  
 
6.1.2.2 Clinical component 
Having one or more diseases (comorbidities) was significantly associated with lower QoL 
(aOR: 0.73; CI: 0.56-0.95). Experiencing bothersome side-effects of ART and self-reported 
HIV-related symptoms also correlated significantly with lower QoL (aOR: 0.76; CI: 0.58-
1.00 and aOR: 0.66; CI: 0.47-0.93, respectively). 
 
6.1.2.3 Psychological component 
Hopelessness was significantly associated with lower ratings of QoL among people living 
with HIV included in this study. Compared to respondents who reported no feelings of 
hopelessness, respondents who reported mild hopelessness and moderate-severe hopelessness 
reported significantly lower QoL (aOR: 0.53; CI: 0.39-0.72 and aOR: 0.11; CI: 0.07-0.16, 
respectively). Negative self-image, the internalization of stigma on oneself, was also 
associated with lower QoL. Compared to reporting low internalized stigma, reporting fairly 
high negative self-image and high negative self-image was significantly associated with 
lower QoL (aOR: 0.66; CI: 0.49-0.89 and aOR: 0.62; CI: 0.39-0.99, respectively). However, 
other stigma mechanisms assessed, including personalized and anticipated stigma (disclosure 
concerns and concerns with public attitudes toward people living with HIV), were not 
associated with QoL. Satisfaction with HIV-disclosure was not significantly associated with 
QoL 
 
6.1.2.4 Sexual life component 
Experiencing negative changes in one’s sex life after HIV diagnosis was significantly 
associated with lower ratings of QoL among study respondents (aOR: 0.65; CI: 0.45-0.95). 
Sexual dissatisfaction was also negatively associated with QoL (aOR: 0.47; CI: 0.35-0.62).  
 
6.1.2.5 Personal resource and social support component 
Feelings that life had become less meaningful after HIV diagnosis were significantly and 
negatively associated with QoL (aOR: 0.52; CI: 0.36-0.74). HIV-related support from others 
was not associated with QoL. 
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6.2 SEXUAL SATISFACTION AMONG PEOPLE LIVING WITH HIV (PAPER II) 
6.2.1 Respondents characteristics 
Table 6 describes the sociodemographic and HIV-related characteristics of respondents.  
6.2.2 Factors associated with sexual satisfaction among people living with 
HIV  
About one-half (51%) of respondents reported being fairly satisfied, satisfied or very satisfied 
with their sex life on a six-point scale ranging from very dissatisfied to very satisfied. No 
significant differences were observed between heterosexual and non-heterosexual men and 
women and sexual satisfaction.  
Below, I present the results from the of path analyses of sexual satisfaction among men and 
women by presenting significant (p ≤ .05) direct and indirect associations with sexual 
satisfaction for each component of analysis (Figure 4 and Figure 5).  A path analysis is an 
extension of multiple regression, often used to analyse models which are more complex than 
multiple regression [200]. Differently from multiple regression, a path model has several 
dependent variables and the association between dependents variables and independent 
variables are assessed simultaneously [200]. 
 
6.2.2.1 Sociodemographic component  
Among both women and men, not being in a relationship was associated with the experience 
that sex life had changed in a negative way and thus had an indirect negative effect on sexual 
satisfaction. Among women, there was an indirect association between country of birth other 
than Sweden and sexual dissatisfaction, via experiencing that HIV had changed their sexual 
life in a negative way (aOR: 0.30; CI: 0.14-0.65).  
 
6.2.2.2 Clinical component 
For both women and men, lower self-reported CD4 cell count was indirectly associated with 
sexual dissatisfaction through the variable negative HIV-related changes in their sex life (for 
women: aOR: 0.27; CI: 0.11-0.68; for men: aOR: 2.12; CI: 1.28-3.52). Among men, 
experiences of side-effects from ART were indirectly associated with sexual dissatisfaction, 
an association which was moderated by experiencing higher concerns about public attitudes 
towards people with HIV and by sexual inactivity.  
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6.2.2.3 Psychological component 
HIV stigma did not play a role in sexual dissatisfaction in the female path diagram, but did so 
for men: high concerns about public attitudes towards people living with HIV were directly 
associated with sexual dissatisfaction (aOR: 0.58; CI: 0.36-0.94).  Feelings of hopelessness 
were a significant direct contributor to less satisfying sex life among men (aOR: 0.30; CI: 
0.18-0.50).  Among women, hopelessness had an indirect association with sexual 
dissatisfaction via distress over orgasmic difficulties (aOR: 3.23; CI: 1.55-6.72). 
 
6.2.2.4 Sexual life component 
Women and men experiencing that their sex life had changed in a negative way after the HIV 
diagnosis were also sexually dissatisfied to a larger extent (among women: aOR: 0.05; CI: 
0.02-0.14; among men: aOR: 0.23; CI: 0.12-0.42). Perceiving the obligation to disclose their 
HIV status to a sexual partner as an obstacle to finding a long-term partner was an indirect 
contributor to sexual dissatisfaction among women and men.  For women, this obstacle was 
associated with sexual dissatisfaction indirectly through experiencing negative changes to sex 
life after HIV diagnosis (aOR: 2.31; CI: 1.16-4.62). For men, the HIV disclosure obligation 
was also associated with HIV stigma related to concerns about public attitudes towards 
people living with HIV (aOR: 2.05; CI: 1.37-3.06) and to feelings of hopelessness (aOR: 
2.39; CI: 1.60-3.57).  
 
Sexual inactivity in the last 6 months had a direct negative effect on sexual satisfaction 
among men and an indirect negative effect among women. No direct associations were found 
between orgasmic, erectile, and ejaculatory difficulties and sexual satisfaction. However, 
these sexual difficulties had an indirect, negative effect on sexual satisfaction via orgasmic, 




Figure 4. Path diagram, female participants (n=320)    
Figure 5. Path diagram, male participants (n=762)    
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6.3 SELF-RATED HEALTH, SELF-REPORTED DISABILITY AND QUALITY OF 
LIFE AMONG TRANS PEOPLE (PAPER III)  
6.3.1 Respondents characteristics 
Table 7 describes the sociodemographic characteristics of study participants. In short, the 
trans experience, i.e. self-identified gender identity and trans identity, of respondents was 
diverse: 19% were trans feminine, 24% trans masculine, 44% were non-binary and 14% self-
identified as transvestites. The age of respondents ranged from 16 to 94 years with a mean 
age of 33.3 years. Respondents were represented from all 21 counties across Sweden and the 
vast majority of respondents were born in Sweden (92%).  
 
Table 7. Characteristics of respondents in Paper III & IV (n=796) 
Characteristic n (%) 
Trans experience    
Trans feminine 149 (19) 
Trans masculine  187 (24) 
Non-binary  346 (44) 
Cross-dresser  112 (14) 
Assigned sex at birth   
Female  388 (49) 
Male 360 (45) 
Age categories   
16–19 82 (10) 
20–29  342 (43) 
30–44 202 (25) 
45–64 130 (16) 
65–94 39 (5) 
Country of birth  
Sweden  729 (92) 
Other than Sweden  67 (8) 
County  
Urban county 504 (65) 
Semi-urban/rural county  269 (35) 
Employment status   
Working/studying 560 (72) 
Unemployed/long-term sick leave 156 (20) 
Retired 34 (4) 
Other 33 (4) 
Education  
No high school education 150 (19) 
Upper-secondary education, or some university 400 (50) 
University education ≥ 3 years 230 (29) 
Other 16 (2) 
Monthly net income (€)  
0–1416  425 (54) 
1417–2125  98 (12) 
2126–3238  145 (18)  
>3239 80 (10) 
Legal gender recognition   
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No, and do not need to  157 (20) 
Yes 114 (14) 
No, but would like to  298 (38) 
No, and cannot change legal gender because the desired gender is not 
available in Sweden today 
207 (26) 
Need for gender-affirming healthcare  
No need  129 (16) 
Need unfulfilled  227 (28) 
Need (partly) fulfilled  318 (40) 
Do not want to answer  116 (15)  
 
6.3.2 Factors associated with health outcomes among trans people  
Trans people reported a median score of 6 on a QoL scale ranging from 0 to 10 where 0 is the 
lowest possible QoL and 10 is the highest possible QoL. About one-half (52%) of the 
respondents reported good or very good self-rated health and about one-fifth (18%) poor or 
very poor self-rated health. Self-reported disability, i.e. a physical or mental conditions that 
the respondent perceived limited their everyday life or work ability to some extent, was 
reported among 53% of respondents.   
 
QoL, self-rated health and self-reported disability among trans people and their contributors 
are presented below by clustering the significant factors (p ≤ .05) from multivariate 
regression analyses into individual levels factors (intrapersonal), community factors and 
structural-policy factors (socio-ecological model) [179].  
 
6.3.2.1 Intrapersonal factors 
Trans experience was significantly associated with self-rated health and self-reported 
disability. Specifically, identifying as gender non-binary, compared to identifying as trans 
feminine, was significantly associated with poor self-rated health (aOR: 2.19; CI: 1.24-3.84)  
and with increased odds of reporting a disability (aOR: 2.18; CI: 1.35-3.54). Age was 
significantly associated with overall QoL: older respondents, compared to young respondents 
(16–19 years), reported higher QoL significantly more often (aOR: 2.62; CI: 1.37-4.98). In 
addition, illicit drug use was significantly associated with poorer self-rated health (aOR: 2.29; 
CI: 1.33-3.95) and QoL (aOR: 0.41; CI: 0.21-0.78).   
 
6.3.2.2 Community factors 
Unemployment or being on long-term sick leave were significantly associated with poorer 
self-rated health (aOR: 2.59; CI: 1.70-3.97), self-reported disability (aOR: 3.51; CI: 2.05-
6.00) and lower QoL (aOR: 0.39; CI: 0.24-0.63). Similarly, income was associated self-
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reported disability and with poorer self-rated health; higher income was associated with less 
self-reported disability (aOR: 0.51; CI: 0.28-0.94) and lower income with poorer self-rated 
health (aOR: 1.80; CI: 1.08-2.99). 
 
Lack of practical support from others was significantly associated with poor self-rated health 
(aOR: 2.57; CI: 1.47-4.48) and lower QoL (aOR: 0.21; CI: 0.11-0.42). Similarly, lack of 
social support was associated with poorer self-rated health (aOR: 1.64; CI: 1.11-2.42) and 
lower QoL (aOR: 0.49; CI: 0.31-0.77). Having a history of negative healthcare experiences 
was associated with poorer self-rated health (aOR: 1.92; CI: 1.26-2.91), lower QoL (aOR: 
0.56; CI: 0.36-0.88) and with self-reported disability (aOR: 2.33; CI: 1.54-3.52). 
 
6.3.2.3 Structural/public policy factors  
Lack of legal gender recognition was significantly associated with poorer QoL (aOR: 0.33; 
CI: 0.18-0.59) and self-rated health (aOR: 2.82; CI: 1.48-5.37).  
 
6.4 SEXUAL HEALTH AND SEXUAL SATISFACTION AMONG TRANS 
PEOPLE (PAPER IV) 
Table 7 illustrates the characteristics of study respondents.  
6.4.1 Sexual health indicators and factors associated with sexual 
satisfaction among trans people  
Nearly one-half (46%) of respondents reported being sexually satisfied. The majority (60%) 
of participants had a current sexual partner: 44% had one current sexual partner and 16% had 
multiple current sexual partners. Nearly one-half (44%) reported not using a condom during 
(vaginal/anal) sexual intercourse with a current sexual partner because it was not necessary 
for the type of sex practiced. Never testing for HIV was reported among 40% of participants 
and the most common reason for not testing was being in a committed relationship with a 
person without HIV. However, one-third (34%) did not know of a clinic where they could get 
tested and get welcoming treatment. Participants reported doubt about the possibility of being 
able to discuss sexual matters within a healthcare context (58%). However, 17% reported 
wanting to discuss sexual matters with healthcare providers. A history of sex in exchange for 
money was reported among 12% of participants. The most common reasons for engaging in 
sex in exchange for money were financial. Over one third (37%) of participants reported 
having experienced sexual violence at some point in life.  
Below, factors significantly associated (p ≤ .05) with sexual satisfaction in the multivariate 
regression analysis are presented for each component of the socio-ecological model [179].  
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6.4.1.1 Intrapersonal factors 
Many of the intrapersonal factors analyzed were not associated with sexual satisfaction, 
including trans experience (i.e. trans feminine, trans masculine, non-binary or cross-dresser), 
living according to one’s gender identity, sexual orientation, hormone use and sexual 
violence.  The only factor that remained significantly associated with lower sexual 
satisfaction in the multivariate analysis was experiencing negative mood symptoms (aOR: 
2.03; CI: 1.00-4.12).  
 
6.4.1.2 Interpersonal factors 
Factors related to personal relationships were significantly associated with sexual satisfaction. 
Compared to respondents with one current sexual partner, respondents with multiple current 
sexual partners reported higher odds of being sexually satisfied (aOR: 0.21; CI: 0.10-0.47).  
Similarly, respondents who were satisfied with their intimate relationship were more often 
sexually satisfied (aOR: 4.24; CI: 1.91-9.40).  
 
6.4.1.3 Community and structural factors 
Experiences of sex in exchange for money was significantly associated with lower sexual 
satisfaction (aOR: 2.64; CI: 1.19-5.84). In addition, perceiving that it was not possible to talk 
about sexual health issues in a healthcare context was associated with sexual dissatisfaction 
among trans people in the study (aOR: 2.18; CI: 1.18-4.02). Lack of legal gender recognition 
was not significantly associated with sexual satisfaction. 
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7 DISCUSSION 
This project sought to examine QoL and sexual health among trans people and people living 
with HIV. Below, I discuss my main findings from each paper included in the thesis.  
7.1 QUALITY OF LIFE AMONG PEOPLE LIVING WITH HIV (PAPER I) 
The majority of respondents reported high levels of QoL (63% reported scores ≥7 on a 0–10 
scale), implying that many people are living positively with HIV. This corresponds with 
results from previous studies [40–42]. With that said, over one-third reported lower rates of 
QoL. Lower ratings of QoL were correlated with hopelessness, internalized stigma and 
negative changes to sex life after HIV diagnosis, indicating that, for many respondents, HIV 
is still a barrier to living a fulfilling life. Our findings strengthen previous discussions about 
the need for a shift in focus on health outcomes beyond viral suppression for people living 
with HIV [58].  
 
7.1.1 Sociodemographic and behavioral factors  
QoL was not significantly associated with gender, age, country of birth, education level, 
employment status and income among respondents in this study. This is in contrast to recent 
findings from Finland which found sociodemographic factors, including gender, financial 
situation, employment and relationship status, to be the main factors associated with QoL 
among people living with HIV included in their study [40]. Other findings suggest that 
ethnicity is significantly associated with QoL among people living with HIV [42,43]. In 
contrast, our findings suggest no differences with regard to birth origin and QoL. It is 
interesting and surprising that there were no differences in reported QoL between people with 
various sociodemographic characteristics even though we have a good representation of 
diverse backgrounds (41% were born outside Sweden/Europe, 29% were women, 43% non-
heterosexual, 25% outside of the workforce, 19% with low education and 55% with lower 
income). It is possible that differences between the results in our study and the above-
mentioned studies [40,42,43] are related to differences in sample size as well as the way 
analyzed variables were categorized. The current study includes a larger sample size and 
many sociodemographic (and other) variables were condensed for analyses but not 
dichotomized, in order to identify potential differences between various characteristics. In 
addition, QoL was assessed using different instruments, also contributing to potential 
differences in independent associations. It is nevertheless possible that the lack of 
associations between sociodemographic factors and QoL in the current study is related to 
inclusion of factors in the analysis that were not assessed in the above-mentioned studies and 
that could have mediated the associations between sociodemographic factors and QoL in the 
multivariate regression analysis. These factors include sex life factors, HIV-related stigma, 
alcohol consumption and homelessness.  
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7.1.2 Psychological factors  
Hopelessness, which is a core marker of depression, was highly prevalent among study 
respondents and was, not surprisingly, correlated with lower QoL. High rates of anxiety and 
depression among people living with HIV are reported from other studies in various settings 
[201–204]. It is possible that hopelessness is related to HIV status and its consequences on 
physical, psychological, sexual and social aspects of life, such as stigma [76]. However, 
hopelessness can also be unrelated to HIV or perhaps related to a pre-existing condition 
before HIV infection. A feeling that life is less meaningful after HIV diagnosis also 
correlated with lower QoL. 
Both feelings of hopelessness and a less meaningful life are important mental health aspects. 
HIV in itself might not be the ultimate reason for feelings of hopelessness, it may be related 
to other social, financial and health-related constraints. However, these adverse feelings are 
important to address, for example when healthcare providers meet people living with HIV in 
order to promote good and healthy lives among people living with HIV including healthy 
life-styles, adherence to treatment and prevention and/or management of comorbidities.  
 
We found that negative self-image related to one’s HIV, i.e. internalized stigma, was 
correlated with QoL. The negative association between internalized stigma and QoL has been 
confirmed in other settings as well [69,70]. An earlier study from Sweden attempted to find 
correlations between HIV-related stigma and HRQoL among 173 people living with HIV 
with full access to ART using a similar HIV stigma instrument as we did in the current study 
[71]. The findings from the above-mentioned study suggested that negative self-image was 
correlated with lower emotional wellbeing. Further, it was found that one aspect of 
anticipated stigma (concerns about public attitudes) was associated with physical functioning 
[71]. The same study, contrary to expectations, did not find the other examined stigma 
mechanisms (disclosure concerns and personalized stigma) to be associated with any 
dimensions of QoL [71]. The hypothesized explanation for that was that, in the current 
contexts of good treatment outcomes, viral suppression and good overall physical health 
among people living with HIV, HIV-related stigma might have a different or less of an effect 
on QoL [71].  
 
Similarly, in the current study, we did not find associations between anticipated stigma 
(disclosure concerns and concerns about public attitudes), personalized stigma and QoL 
among study respondents. While the internalization of stigma and endorsement of HIV-
associated negative believes about oneself was significantly associated with overall QoL, it is 
possible that anticipated and enacted stigma may have a less prominent effect in one’s life 
when it is possible to keep HIV private and the health effects of HIV in everyday life are 
minimal. The conceptualization of stigma as it is used here [78,205] and in most other 
research is based on theory building prior to the introduction of effective treatment [77]. The 
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different ways that HIV-related stigma was experienced by people living with HIV who were 
virally suppressed was presented  in a recent qualitative study from Sweden [77].  It was 
found that while internalized stigma was experienced in similar ways as conceptualized by 
Earnshaw and colleagues, enacted and anticipated stigma were more complex. The reason for 
that was that people did not necessarily experience individual stigmatizing encounters but 
rather endorsed other people’s encounters with HIV-related as their own [77].   
 
7.1.3 HIV-related support  
Although HIV-related support was significantly associated with better QoL in the univariate 
analyses, it did not remain significant in the multivariate regression analysis, when other 
variables were taken into account. Social support among people living with HIV was 
previously found to be correlated with better QoL [42,53,206] and was identified as a buffer 
for depressive symptoms [206]. Studies use different instruments to assess social support, as 
well as take different factors into account in their analysis, which could result in 
over/underestimation of the significance of some variables.  Few studies have included a 
comprehensive analysis of factors related to sociodemographic factors, sexual health, clinical 
factors, psychological factors and social support when assessing QoL [42]. In the current 
study, one-third of respondents had no one they could turn to for HIV-related support. 
Related to our findings about HIV-related stigma and hopelessness, it is possible that the need 
for HIV-related support is not perceived as important as we assumed but rather that other 
support needs are more prioritized.  In conjunction with that, only 15% reported that they 
were affiliated to a HIV-support organization. Neither can it be ruled out that lack of 
association is related to methodological aspects, such as the categorization of the variable 
HIV-related support and possibly low statistical power.  
 
7.1.4 Sex life factors 
Negative changes in sex life after HIV diagnosis and sexual dissatisfaction were associated 
with lower QoL. Few studies assess sexual aspects of the lives of people living with HIV 
with regard to QoL, despite the central role that sexual life has on overall QoL and the sexual 
challenges people living with HIV may face [207]. Nearly two-thirds of respondents in the 
current study reported that their sex life had changed negatively after they were diagnosed 
with HIV (data not shown): 20% reported that after HIV diagnosis, their sex life changed 
negatively because of the difficulty in finding a steady partner and 27% that they totally 
avoided having sex after their diagnosis. These findings indicate that HIV constitutes a 
barrier for many people in forming relationships and restricts their life.  These results 
emphasize the importance of sexual health for QoL and the need to address these issues in the 
care for people living with HIV.   
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7.1.5 Clinical factors  
Clinical factors including perceived ART side-effects, HIV-related symptoms and 
comorbidities were correlated with lower QoL. A non-negligible proportion of respondents 
experienced various ART side-effects (34%) and 20% perceived HIV-related symptoms 
despite the majority being virally suppressed and on ART for many years. Several recent 
studies conducted in high-income settings where effective ART is widely available and 
accessible have reported both low and high burden of perceived side-effects among people 
living with HIV [42,208,209]. The consequences of experiences of side-effects or symptoms, 
beside decreasing one’s QoL [42,210], may also affect adherence to treatment [209].  It is 
therefore important that healthcare providers discuss any perceived and experienced adverse 
effects of ART with their patients, and do not make assumptions or neglect this problem just 
because the patient is virally suppressed. It is possible that people who experience treatment 
side-effects take these experiences for granted, i.e. think that it is a normal reaction and thus 
do not communicate this with their doctors. In addition, it is possible that various adverse 
effects are unrelated to HIV or to ART but are perceived as being associated because it may 
be very difficult for an individual living with HIV to identify and differentiate between HIV 
or ART symptoms or other symptoms caused by, for example, age, other stressors and other 
medications. 
 
Similar to other studies [55–57,59], respondents reported high rates of comorbidities such as 
hepatitis C, high blood pressure and psychiatric condition. Comorbidities were associated 
with lower QoL, as reported from other settings [40,42,43,211]. The high burden of 
comorbidities among people living with HIV is expected to increase as more live longer lives 
[212].  This increase represents an important rationale for regularly monitoring various risk 
factors in order to prevent and early detect different comorbidities, such as cardiovascular 
disease, diabetes, depression, kidney or liver dysfunctions and various forms of cancer that 
are more common among people living with HIV [212]. It is nevertheless important to 
address life-style related risk factors among people living with HIV. For instance, the 
percentage of current smokers among participants in this study is threefold that of the general 
Swedish population (28% among study participants compared to 9% in the general 
population [213]) and hazardous alcohol consumption, also associated with lower QoL, was 
reported among 18% of respondents. Various life-style related comorbidities could also be 
prevented by addressing poor mental health issues among people living with HIV [214].  
 
7.2 SELF-RATED HEALTH, SELF-REPORTED DISABILITY AND QOL AMONG 
TRANS PEOPLE (PAPER III) 
Trans people in this study reported high rates of poor self-rated health and self-reported 
disability compared to the general population. Lower ratings of QoL were considered as 
scores below the median cut-off of (6). The proportion of poor or very poor self-rated health 
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in the general Swedish population was 5% in the same year as our study was conducted 
[213], as compared to 18% of the trans people in this study. Moreover, self-reported 
disability, i.e. a physical or mental condition that impairs everyday life or work ability was 
high: 53% among trans people compared to 26% in the general population in 2015 [213]. 
Self-reported disability is subjective and respondents reported to what extent they felt it 
affected them. Not all respondents who reported a disability specified whether it was related 
to somatic or mental conditions. Among those who did, the main conditions which were 
reported were related to mental health.   
 
Self-reported health outcomes were associated with factors such as income, employment and 
age, which are common health determinants for all people. However, in addition to these 
common health determinants, trans people included in this study faced specific distal 
institutional and structural challenges which were associated with their trans identity. 
According to the minority stress theory, minority stress is additive to general stressors that are 
experienced by all people, which is what makes these stressors unique [176]. 
Below, I discuss the results from Paper III according to the different factors included in the 
socio-ecological model. 
 
7.2.1 Intrapersonal factors  
For trans people included in this study, lower QoL was associated with belonging to the 
youngest age-group studied, 16–19 years. Young age is characterized by physical, 
psychological and social changes which could be extra stressful for trans people. Young age 
is also a more vulnerable time with regard to being more susceptible to minority stressors 
including victimization and limited social support [215].  
 
Our findings indicated that respondents identifying as non-binary, i.e. people whose gender 
identity and/or gender expression falls outside the categories of man and woman, had 
increased odds of reporting a disability and poor self-rated health.  Non-affirmation in gender 
identity by others is an element that differentiates gender minority stress from sexual minority 
stress [177]. For non-binary people, this non-affirmation is perhaps experienced to a larger 
extent compared to other trans people. This is because society might fail to address non-
binary people in a gender-neutral way, because non-binary people’s gender identity is not 
legally recognized in most countries, including Sweden, and because physical environments 
such as dressing rooms and public bathrooms are often gender binary. Earlier studies which 
report on health outcomes among non-binary people found that they report high levels of 
depression and anxiety [216] and that, compared with trans-binary people, non-binary people 
were more likely to report discrimination [217] depression, anxiety and lower self-esteem 
[218]. A recent Swedish report from 2017 similarly found that non-binary people experience 
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misgendering, i.e. the misclassification of gender identity, more often compared to other trans 
people [219]. Non-binary people may thus experience elevated social stress because they 
deviate from the strong gender norms that dominate in society. 
 
Shortly after this study was conducted in 2015, new national guidelines were adopted with 
regard to the evaluation and treatment of trans people, “Good care of adults with gender 
dysphoria” [175]. These guidelines acknowledge the need for individualized care where 
different patients have different gender-affirming needs [175]. The new guidelines increase 
non-binary people’s access to gender-affirming care. It is thus possible that non-binary 
respondents reported poorer health outcomes also because of limited possibilities to access 
gender-affirming care, in particular when the data collection was performed.  
 
7.2.2 Community factors  
7.2.2.1 Interactions with healthcare providers  
In this study, negative healthcare experiences were associated with poorer health outcomes 
(i.e. self-rated health, self-reported disability and QoL). Recent qualitative findings from 
Sweden echo our findings that many trans people experience difficulties when interacting 
with healthcare providers and experience lack of knowledge about trans-related issues and 
feeling of non-affirmation in their gender identities in encounters with healthcare 
professionals  [220].  
Inadequate access to competent healthcare services has been identified as a key health issue 
among trans people [125,127,128]. It is important to highlight that 69% of respondents, who 
were coded here as “experienced negative health care experiences”, did not necessarily 
experience negative treatment by health care providers per se: some experienced respectful 
encounters albeit characterized by a lack of knowledge about trans-related issues (Figure 6).  
 
7.2.2.2 Social and practical support  
Social support, another polar of the minority stress model in providing resources that act as 
stress buffers [176], was confirmed among study respondents: having social and practical 
support was positively associated with better QoL and better self-rated health. Social support 
was found to be acting as a protective factor associated with mental health among the 
Swedish LGB population [215]. Despite the positive effects of social support, it has been 
suggested that trans people may have limited social support, which is associated with poor 
mental health [221,222]. Limited social support could be lacking due to prejudice and 
rejection by family members, which in itself is attributed to poor mental health [218].  
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Figure 6. Experiences of respondents in encounters with healthcare providers (n=796) 
7.2.3 Public policy factors  
7.2.3.1 Non-affirmation of gender identity   
A wish to change legal gender or the lack of opportunity to do so because the desired gender 
is not available (legal gender recognition is impossible for non-binary people), was correlated 
with poorer self-rated health and QoL. For many trans people, gender affirmation is a 
multifaceted process which includes social affirmation (e.g. name and pronoun), 
psychological (e.g. internal, felt-self), medical (e.g. cross hormones, surgery) and legal 
gender affirmation (e.g. legal gender recognition and change of name) [115]. It was 
previously found that social, psychological and medical affirmation among trans women were 
correlated with less depression and higher self-esteem [139]. Correlation between lower QoL 
and lack of legal gender affirmation could be explained by the daily reminders of this lack of 
affirmation as a result of interaction with bureaucracy and society.   
 
7.3 SEXUAL SATISFACTION AMONG PEOPLE LIVING WITH HIV (PAPER II) 
The proportion of respondents who were dissatisfied or very dissatisfied with their sexual life 
in this study was 33%, which is three times the proportion that was reported in the general 
Swedish population, using the same instrument [223]. No significant associations were 
observed when non-heterosexual men, heterosexual men and women were compared. Rates 
of sexual satisfaction (50% rather satisfied, satisfied or very satisfied) in this study were 
similar to rates reported in other studies [80,83,84,86,87]. We found a complex interaction 
between direct and indirect factors related to sexual satisfaction including sociodemographic, 
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clinical, psychological and sexual factors. While some factors related to sexual satisfaction 
were clearly HIV-related, others could not be ruled out as unrelated to HIV.  
7.3.1 Sociodemographic factors  
Not being in a relationship was, for both women and men, associated with HIV-related 
negative changes to sex life and had an indirect effect on sexual dissatisfaction. Although we 
cannot say for certain that not being in a relationship is related to HIV, it is possible that some 
participants were not in a relationship unwillingly. This assumption is strengthened by 
previous research which report high levels of loneliness and social isolation among people 
living with HIV which are largely explained by stigma [224–227].  
7.3.2 Psychological factors   
Anticipated HIV-related stigma was directly associated with sexual dissatisfaction, only 
among men, which is supported by previous studies [83]. Men who experienced high 
concerns about public attitudes reported higher sexual dissatisfaction. This association was 
combined with finding the legal obligation to disclose HIV-status an obstacle to finding long-
term partner, which explains how these two concerns may fuel each other and contribute to 
sexual dissatisfaction among men. Interestingly, negative self-image was not associated with 
sexual dissatisfaction. This is in contrast to our findings with regard to overall QoL. One 
probable explanation is that in the sexual context, the type of stigma that dominates is related 
to public attitudes and fear of rejection rather than the internalization of stigma.  
 
The importance of the mental health state of people living with HIV with relation to various 
aspects of life is further confirmed by our finding that hopelessness was directly associated 
with sexual dissatisfaction among men and indirectly among women, via distress over 
orgasmic difficulties. Mental health is also closely related with various aspects of sexual 
health including sexual function [228,229] and satisfaction [95] but too often neglected in the 
clinical HIV care/infectious disease setting. 
 
7.3.3 Sex life factors   
Similarly to previous studies among people living with HIV, we found an association 
between sexual inactivity and sexual dissatisfaction [83,84]. Previous studies suggest that 
both intentionally and unintentionally abstinence among people living with HIV is common 
and is a coping strategy to avoid rejection and fear of disclosure  [80,230]. In addition, 27% 
of study respondents reported that they stopped having sex after their HIV diagnosis, which 
leads us to believe that sexual inactivity could, at least to some extent, be associated with 
HIV.  
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HIV-related negative changes to sex life were, not surprisingly, significantly associated with 
sexual dissatisfaction among both women and men. After an HIV diagnosis, the individual’s 
sex life becomes fraught with restrictions. This finding is also identified in Paper I with 
regard to QoL. Negative changes to sex life after HIV was related to experiencing the legal 
obligation to disclose HIV status as an obstacle to long-term relationships. The application of 
this legal obligation has been modified since 2013 and today treating physicians can exempt 
their patients from this obligation under the condition that patients are durably virally 
suppressed and condoms are always used during sexual intercourse. However, despite these 
exemptions, people still face dilemmas regarding how and when to disclose their HIV status 
to sexual partners and need to weigh the possibilities that casual sexual relationships might 
develop to long-term ones. Further, recent evidence suggests that not all people living with 
HIV who are eligible for these legal exemptions are informed about this right [98]. Our 
findings, in combination with this recent evidence, suggest that this legal obligation still has a 
significant impact on people’s lives, in particular their sexual life – thus, much more 
information is needed, to health providers and people living with HIV about the new 
interpretation of the law since 2013, and, to the public about treatment as prevention (TasP) 
and the strong evidence of minimal transmission when on ART.   
 
7.4 SEXUAL HEALTH OUTCOMES AND SEXUAL SATISFACTION AMONG 
TRANS PEOPLE (PAPER IV) 
The proportion of respondents who reported being dissatisfied or very dissatisfied with their 
sex life (34%) was three times that of the general Swedish population [223]. Factors 
associated with sexual satisfaction among trans people in this study included expected factors 
which were previously found to be associated with sexual satisfaction among various 
populations including relationship satisfaction and absent of negative mood symptoms [7]. 
However, our findings also revealed associations between sexual satisfaction and multiple 
sexual relationships and possibilities to discuss sexual matters within the healthcare context, 
which were not previously reported. In addition, our findings also shed light on different 
aspects of sexual health including condom use, HIV testing and access to sexual health 
services among study respondents which have not been presented before in a Swedish 
context. Our findings also revealed an unmet sexual healthcare need as well as a need to 
contextualize sexual risk.  
By examining both distal and proximal variables, we attempted to find out whether, in 
addition to individual and relational factors, other institutional and structural factors were 
significant contributors to trans people’s sexual satisfaction, in accordance with the concepts 
of the socio-ecological model [12].  
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7.4.1 Intrapersonal factors  
At the intrapersonal level, the only variable that was significantly associated with sexual 
dissatisfaction was experiences of negative mood symptoms. Previous studies found a 
correlation between depressive symptoms and sexual dissatisfaction among cis-and-trans 
people [12,160,231].  
In contrast to expected and to previous research [160], we did not find an association between 
sexual satisfaction and being able to live according to gender identity and met or unmet needs 
for gender-affirming intervention. It has previously been demonstrated that Dutch trans 
people with unmet gender-affirming healthcare needs were significantly more likely to 
experience body dissatisfaction, which was associated with sexual dissatisfaction [160]. We 
did not assess body satisfaction in this study, which is perhaps a better indicator than gender-
affirming healthcare needs, with regard to sexual satisfaction. Another possible explanation 
for the lack of association could be that people cope with different conditions and 
circumstances and that despite gender dysphoria, trans people may find a way to enjoy their 
sexuality [133]. It is also possible that the indicators that we used to assess gender-affirming 
healthcare needs were not sufficient in capturing the situation among study respondents.   We 
used a proxy for gender-affirming healthcare needs by analyzing whether a person has the 
desire to and has started the bureaucratic procedure of seeking gender-affirming healthcare. 
However, we did not ask which procedures a person wished to perform nor whether or not 
these wishes were fulfilled.  
 
Hormone use was also not found to be associated with sexual satisfaction in the multivariate 
analysis, which contradicts previous findings [170]. It is possible that while hormone use 
might affect sexual desire, it does not necessarily mean it also affects satisfaction. The effects 
of hormonal therapy is not only determined by biological factors but also by psychosocial 
factors which are important predictors of sexual satisfaction [133].  
 
7.4.2 Interpersonal factors  
At the interpersonal level, we found that, in comparison to having one current sexual partner, 
having multiple sexual partners was correlated with higher sexual satisfaction.  Multiple 
sexual partners is often seen in a context of risk behavior and is rarely presented in other 
contexts [232]. Nearly every fourth (16%) respondent reported currently having more than 
one sexual partner. A similar proportion was found among a Canadian cohort of trans people 
[233], emphasizing the need to step out of the normative perspective of monogamous 
relationships when assessing relationship types in research.  
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Another relational variable that was significantly associated with sexual satisfaction was 
relationship satisfaction, which is in line with previous research on sexual satisfaction in 
cisgender populations [12,234]. It is not surprising that sexual satisfaction is higher in a 
relationship that thrives and when one is satisfied with one’s relationship.  Qualitative 
findings among trans people describe the importance of respectful and loving intimate 
relationship for overall sexual health [163].  
 
7.4.3 Institutional factors  
With regard to institutional factors, we found that experiencing a lack of opportunity to 
discuss sexual matters in a healthcare context was associated with lower sexual satisfaction. 
Feeling that it is hard to discuss sexual matters with healthcare providers is perhaps not 
unique to trans people. It was previously found that both healthcare providers and (cisgender) 
clients may find it difficult [235]. However, for trans people, it might be particularly 
challenging because of previous negative encounters with healthcare providers or 
expectations of incompetence with regard to trans-related issues [236,237]. 
 
Experiences of sex in exchange for money were associated with lower sexual satisfaction. 
Transactional sex among trans women in particular has been identified as a symptom of 
societal and economical marginalization [238] and is associated with increased risk of HIV 
[158]. In this cohort, 12% have reported experiences of sex in exchange for money. A 
Canadian study found similar numbers [239]. In this context, it is important to keep in mind 
that Sweden is a country with different social, medical and legal conditions compared to 
many other countries: gender-affirming healthcare is included in the national healthcare 
insurance and discrimination against trans people in employment, healthcare provision, 
housing and other sectors is prohibited by law [172]. Yet, marginalization of trans people still 
exists and limits the inclusion of trans people in society’s different arenas.   
 
7.4.4 Public policy factors  
Surprisingly, legal gender recognition, which is a structural public policy factor, was not 
associated with sexual satisfaction. We assumed that legal affirmation of gender identity was 
a proxy to other types of gender affirmations (social, psychological or/and medical) and 
would thus be positively associated with sexual satisfaction. Previous findings indicate that, 
while gender affirmation is important for sexual satisfaction among trans people, body 
satisfaction is an even more important predictor of sexual satisfaction [160]. We did not 
assess body satisfaction in this study, but it is likely an important aspect for respondents in 
this study as well.  
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7.4.5 Other sexual health indicators  
Some variables have only been analyzed descriptively because we wanted to fill the 
knowledge gap about these sexual health indicators in the Swedish context. Yet, we did not 
consider these variables as predictors of sexual satisfaction. These sexual health indicators 
represent important findings about unmet needs among trans people. For example, 40% of 
respondents have never been tested for HIV. Similar numbers were found in a Canadian 
study [239]. This proportion seems high. However, it was estimated in 2012 that only 11% of 
the general Swedish population had been tested for HIV over the past twelve months [240] 
compared to 24% who had been tested for HIV in the past year among respondents in this 
study. The proportion of testing for HIV needs to be understood in a context of risk. When 
respondents were asked whether they used condoms if having receptive/penetrative 
vaginal/anal sex (an indicator of high-risk sex), the majority replied that they did not practice 
this type of sex and therefore did not need to use a condom. Similarly, Bauer et al. found that 
a relatively small proportion of participants in their study reported having 
receptive/penetrative genital sex with flesh contact and fluid exposure [239].   
 
Even though many participants did not consider that they needed to get tested for HIV, nearly 
20% responded that they did not know where to get tested or that the reason they had not 
been tested was their worry about healthcare providers’ attitudes towards trans people. 
Similarly, one-third of participants did not know of a sexual health clinic where they could 
feel welcome. These numbers are worrying and prevent us from estimating the needs and the 
magnitude of risk in terms of self-reported sexual health outcomes.  
 
With regard to perceived knowledge on how to protect oneself from HIV and other STIs, 
22% participants reported not having sufficient knowledge about how to protect themselves 
from other STIs and 14% from HIV. Summarizing these descriptive findings, it is important 
to keep in mind that trans people represent a heterogeneous group with regard to relationship 
types and sexual practices, which is important in contextualizing and estimating risk and 
needs [239]. In the words of Bauer et al. [239]: “Trans sexuality is not easily captured in 
conventional ways of thinking about HIV-related risk, and our results caution against making 
any assumptions about the types of sex trans people have, the body parts they use, or who 
their sex partners are. This has implications for design of prevention and education 
programs.” 
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7.5 METHODOLOGICAL CONSIDERATIONS 
7.5.1 Selection bias and representativeness  
7.5.1.1 Respondents in the study Living with HIV  
One strength in this project is related to the large size of cohort in the study Living with HIV 
(Paper I & II), which is by far the most extensive self-reported data among people living with 
HIV in Sweden. With that said, we have limited knowledge about the characteristics of non-
respondents in the study. Although we attempted to conduct non-response analysis, we did 
not manage to keep a systematic record of non-responders at all 17 different collaborative 
sites, mainly due confidentiality issues. This prohibited us from listing information on the 
sociodemographic characteristics of those who declined participation in the study. It is 
possible that non-responders share certain characteristics that would have been meaningful 
for this study, such as poorer overall health and higher stigma. With regard to the 
sociodemographic characteristics of non-responders, we can make some assumptions thanks 
to the national quality registry InfCare HIV [15], which provides us with such data. We could 
see that in our cohort certain groups were slightly under-represented including people who 
were born outside Sweden (56% according to InfCare HIV data 2014 and 44% in this cohort) 
and people who said they had been infected with HIV via heterosexual sex (47% according to 
InfCare HIV data in 2014 and 32% in this cohort), which is the largest HIV transmission 
route among migrants. With regard to other characteristics such as sex, HIV transmission 
routes (besides heterosexual sex), county of residence and age, we judge this study cohort as 
representative of the larger population of people living with HIV in Sweden. In addition, we 
made considerable efforts to recruit previously underrepresented groups such as women, 
migrants and people who inject drugs – which we are satisfied with. The questionnaire was 
available in 10 different languages and the help of a translator was available for those who 
needed it. In addition, two needle-exchange centers distributed the questionnaire which 
increased the representation of people who inject drugs.    
 
7.5.1.2 Generalizability of the findings from Living with HIV  
Because of the large sample size and due to the extent to which it represents the population of 
people living with HIV in Sweden, we believe that our results are generalizable. Yet, 
correlations, and lack of correlations that were found in Paper I and II should be interpreted 
with caution. In study II for instance, the findings suggest a more complicated model of 
factors related to sexual satisfaction among men compared to the model for women. This 
could be partly explained by the fact that the group of women was significantly smaller in 
size compared to the group of men, which might have implications for lower statistical 
power, possibly underestimating significant associations, which is also relevant for the lack 
of association between gender and QoL in Paper I.  
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7.5.1.3 Recruitment of participants in the study Health for all    
Another limitation in respect to selection bias is the convenient sampling method that was 
used in the cohort of trans people (Paper III & IV). Study participants were self-selected via 
web-based recruitments in HBTQ-related arenas and by personalized invitations made by the 
research groups’ collaborators. The study population, which resulted from this type of 
recruitment, may not be representative of the entire population of trans people in Sweden. 
Because trans people are a population of unknown size, randomized sampling from the 
population would not be a possible or even appropriate recruitment method and web-based 
surveys become a practical tool to reach a large volume of people.  
 
We cannot make any assumptions about the generalizability of the group included in this 
study and the larger population of trans people due to the convenient sampling that was 
employed for recruitment. With that said, this is the largest volume of self-reported data 
collected in Sweden among trans people and this cohort represents a heterogeneous group of 
people self-identifying as trans, with various gender-affirming healthcare needs. This 
heterogeneity has not been seen in Swedish research on trans people, which is a strength in 
this project.  
 
7.5.2 Instruments and scales  
The main outcomes in this project, namely QoL and sexual satisfaction, were each assessed 
using a single question. This may have an effect on the reliability of these instruments. Our 
aim was to assess overall QoL by exploring different psychosocial, clinical and sexual 
factors, and not HRQoL per se. It was previously shown that a single-item VAS scale 
assessing global QoL is an instrument with as good validity and reliability as multi-item 
questionnaires [241]. In addition, many of our results were confirmed in other studies’ 
findings, also supporting our instruments’ reliability. Another aspect of this use of instrument 
is that it had not been used on previous Swedish data which compromises comparisons with 
regard to level of QoL. Similarly, sexual satisfaction was assessed using a single question, 
which may not represent the multidimensionality of this construct in the same way as a multi-
item instruments might. The instrument that we used has been previously validated in 
Sweden which also provides us with good scope for comparison [223]. It should, however, be 
noted that the Swedish norm data that we compare our results with originates from a study 
conducted in 1998 [242], which may undermine the relevance of these findings.  With that 
said, most of our findings with regard to sexual satisfaction were confirmed in findings from 
other settings and which used other instruments.  
 
Both studies were set up to map out the health and social situation among these populations 
in a broad sense, and as such included many different sections and questions. Retrospectively, 
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it seems like some aspects would have benefitted from receiving more detailed attention. For 
example, the questions regarding sexual health among trans people were more focused on 
risk behavior rather than on positive aspects of sexuality which might have provided us with a 
more holistic picture of sexual satisfaction in this population. Other important factors in 
relation to sexuality, including importance of sex, challenges in forming intimate 
relationships and body satisfaction, would all be highly relevant to assess in relation to sexual 
satisfaction.  
 
7.5.3 Trade-off between different analytical approaches and losing valuable 
information  
The questionnaires that formed the basis of this work included many items that did not have 
mutually exclusive alternatives and could not easily be dichotomized. Many statistical 
approaches within epidemiology are designed for continuous or dichotomized data. However, 
the nature of the data collected here often included variables with multiple categories which 
were hard to dichotomize without losing valuable information. This type of data was 
particularly challenging when I tried to explore other analytical approaches such as structural 
equation modelling (SEM) for paper IV. Not all variables that I was interested in could be 
dichotomized and with the lack of previous studies among trans people, I had no clear 
theoretical model to follow. It is possible that our results could have been more complex and 
detect underlying factors had we been able to use other, more complex models.  
 
7.5.4 Imputation of missing data  
Questionnaires that are lengthy and that contain sensitive issues are bound to suffer from 
missing information. When applying various multivariate regression analyses, each missing 
data point is treated as missing on all other items as well. To decrease the missing data in our 
data, we applied multiple imputation in Papers I and II. Multiple imputation has its 
limitations and may give biased results. In Paper I, even though we performed multiple 
imputation, we coded some variables with missing observations as “do not want to answer”. 
This was done because we believed that missing answers could be significantly associated 
with the outcome.  
 
7.5.5 Study design 
This project is purely quantitative. However, some hypothesized associations that we could 
not confirm in this project, for example the lack of association between social support and 
QoL among people living with HIV, among others, would be interesting to explore more 
qualitatively. The use of only quantitative design is thus limited in explaining all aspects 
related to QoL and sexual satisfaction.   
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7.5.6 Possible exclusion of trans respondents in Paper II 
Because sexual satisfaction is gender-dependent, we assessed sexual satisfaction among 
people living with HIV (Paper II) separately for women and men. This division made us 
exclude participants who reported “other” as their gender identity because these respondents 
were too few to include in a model. Consequently, four respondents were excluded that were 
probably non-binary trans people. In Paper I, however, we included these respondents, 
despite this group’s small size.  
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8 CONCLUSIONS  
 
• A majority of people living with HIV included in the study reported good overall 
quality of life 
• Our findings supported by previous studies emphasize the importance of mental 
health and wellbeing for both QoL and sexual health outcomes among people living 
with HIV in the era of good treatment outcomes and viral suppression  
• For many, QoL is still compromised by HIV infection and associated with 
internalized stigma, negative sexual changes and comorbidities 
• Despite very good treatment outcomes, viral suppression and nearly non-existing 
risk of secondary transmission, people living with HIV included in the study 
experienced that the HIV diagnosis had changed their sex life in a negative way, 
which was associated with sexual dissatisfaction   
• Trans people, and particularly non-binary people included in the study, reported high 
rates of poor health, perceived disability and relatively low QoL 
• Factors related to trans people’s health and QoL are similar to those of the general 
population in addition to trans-related distal factors, such as legal gender recognition 
and experiences of healthcare incompetence in trans-related issues 
• Trans-friendly sexual health services including testing and counselling were needed 
among study respondents  
• There is a need to shift from normative assumptions about sexual relationships, 
practice and sexual risk in order to understand sexual health issues among trans 
people  
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9 RECOMMENDATIONS FOR HEALTHCARE AND POLICY  
Our findings regarding quality of life and sexual health among people living with HIV imply 
that: 
• There is an increasing need to adopt an integrated care approach for people living 
with HIV that is more patient-centered and personalized. The provision of integrated 
care and counselling targeting psychological, sexual and reproductive health issues as 
well as prevention, treatment and management of both physical or psychiatric 
comorbidities is essential. 
• Our results demonstarte and strengthen previous findings about the importance of 
mental health for both overall QoL and sexual satisfaction and underscore the 
importance of incorporating periodic screening and monitoring of symptoms of poor 
mental health within the HIV care.  
• The legal obligation to disclose one’s HIV status to sexual partners has been a major 
obstacle for many people living with HIV to forming intimate relationships and 
having a satisfying sex life. The robust evidence of undetectable = untransmittable, 
which has also lead to legal changes in disclosure obligations, needs to be 
communicated much more effectively to the general public, to people living with HIV 
as well as to healthcare personnel. 
• The negative effects of HIV-related stigma are evident in both self-rated QoL and 
sexual satisfaction. Stigma elimination efforts should be intensified and focus on 
contemporary knowledge about HIV, directed towards both the general public and 
healthcare providers. Since it is not possible to eradicate the social stressors associates 
with stigma, it is important for people living with HIV to have access to both 
psychosocial support and tools to build resilience, self-esteem and self-confidence.  
• Robust tools for regular monitoring and follow-up of the QoL of people living with 
HIV should be scaled up and used in clinical practice and management of HIV.  
 
Our findings from the health, quality of life and sexual health among trans people imply 
that:  
• The healthcare system needs to be more trans-inclusive, for example, by including 
questions of preferred name and pronoun in encounters with people seeking care. 
Knowledge about trans people and trans-specific healthcare should be included in the 
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objectives in the educational programs for all healthcare personal and be a part of 
further training programs. 
• Legal gender recognition should be made simpler and not related to medical 
procedures in order to increase the access of trans people to get their gender identity 
recognized. The inclusion of a third legal gender, that can suit non-binary people 
should be seriously considered in Sweden. 
• Increased knowledge and visibility of trans people is needed in order to deliver 
welcoming and adequate needed mental health services.  
• Educators, counselors and healthcare providers should strive for not having 
assumptive attitudes about trans people’s sexual practices, preferences and 
orientations, thus increasing access to sexual healthcare services for this group.  
 
9.1 COMMON RECOMMENDATIONS FOR RESEARCH AND MEDICAL 
PRACTICE:  
 
• Include the target group concerned in the different phases of research, from the early 
stages of designing the study to translation of findings and the actual finalized product 
in the form of information dissemination and/or interventions. 
• Sexual history taking could be an effective way to explore the different challenges 
patients face with regard to their sexual life and should therefore be used in 
specialized care catering for people living with HIV and within gender-affirming care.  
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12 APPENDICIES 
12.1 APPENDIX 1: LIST OF DATA COLLECTION SITES (PAPER I & II) 
Clinic/site 
1. Karolinska University Hospital, Stockholm 
2. Venhälsan, Stockholm South General Hospital (SöS), Stockholm 
3. Sahlgrenska University Hospital, Göteborg 
4. Skåne University Hospital, Malmö 
5. Gävle Hospital, Gävle 
6. University Hospital of Umeå, Umeå 
7. Örebro University Hospital, Örebro 
8. Helsingborg Hospital, Helsingborg 
9. Sunderby Hospital, Luleå 
10. Falu Hospital, Falun 
11. Needle exchange programme at S:t Görans Hospital, Stockholm and Karolinska 
University Hospital, Stockholm 
12. Kalmar Hospital, Kalmar 
13. Skaraborg Hospital, Skövde 
14. Stockholm’s Drug Users Union, Needle exchange programme by Gullmarsplan, 
Stockholm 
15. Blekinge Hospital, Karlskrona 
16. Astrid Lindgren Children’s hospital, Stockholm 
17. Visby Hospital, Visby 
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12.2 APPENDIX 2: STUDY INFORMATION (PAPER I & II) 
 
LIVING WITH HIV IN SWEDEN  
 
Over a period of four months, more than 1,000 HIV-positive Swedes throughout the 
country will be asked about participating in a study that looks at what it is like to live with 
the condition these days. Up-to-date information about the circumstances and quality of life 
among various population groups is required in order to improve healthcare and other 
social institutions as needed. In other words, your participation will be highly valuable.  
 
How does it work? 
During your appointment at the infection clinic, you will fill out a questionnaire about how 
you are doing and the things that may or may not be difficult for you to deal with at work, 
when travelling, when communicating with the healthcare system or in your personal 
relationships. The questionnaire takes 20-40 minutes to complete. 
 
The questions were put together in collaboration with a number of organisations (including 
HIV Sweden, Noah’s Ark and the Swedish Drug Users Union in Stockholm) that support 
HIV-positive people. You might feel that some of the questions are repetitive or invasive, 
but they are important so that we can compare the responses to those of people in other 
countries. The results of the study will be compiled and made available for anybody who is 
interested in late spring 2014. 
The questionnaire is completely anonymous and voluntary. Nobody will be able to 
make any connection between you and your responses. None of your caregivers will 
have access to your responses.  
You can drop out of the study at any time. The health care you receive will not be affected 
if you decide not to participate in the study. 
 
Who is in charge of the study? 
The study is a collaborative project of the Swedish Institute for Communicable Disease 
Control, Karolinska Institutet, Karolinska University Hospital, Venhälsan and Astrid 
Lindgren Children’s Hospital in Stockholm, as well as infection clinics in Helsingborg, 
Malmö, Karlskrona, Kalmar, Visby, Skövde, Gothenburg, Örebro, Falun, Gävle, Umeå and 
Luleå. Anna Mia Ekström, a professor at Karolinska Institutet and a specialist in infectious 
conditions, is in charge of the study. The Regional Ethical Review Board in Stockholm has 
approved both the study and the questionnaire. 
 
Is there anything you are wondering about? 
If there is anything you would like to ask about the questionnaire, feel free to talk to the 
person who contacted you about participating in the study.  
If there is anything you would like to ask about the study, feel free to call the research 
coordinators at 0735 - 605 942, , or write to Dr Ekström at Automatic citation updates are 
disabled. To see the bibliography, click Refresh in the Zotero tab. 
If there is anything you want to ask about HIV in general, or if you are looking for advice 
from somebody who knows what it is like to live with the condition, contact:  
• Swedish Association for HIV-Positive People at 08-714 54 10 or www.hiv-
Sverige.se  
• Posithiva Gruppen at 0736-24 24 22 orError! Hyperlink reference not valid. 
• National Federation of Noah´s Ark Associations at www.noaksark.org or your local 
association at 020-78 44 40 
•  
Consent to participate in the study “Living with HIV in Sweden” 
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Responding to the questions indicates that you have consented to participate in the study 
and that you realise that your participation is voluntary and that your responses are 
completely anonymous 
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12.3 APPENDIX 3: STUDY INFRMATION (PAPER III & IV) 
 
HÄLSA FÖR ALLA  
En studie for personer med transerfarenhet  
 
Hej! 
Välkommen till vår enkät som handlar om hälsa och livsvillkor för transpersoner! 
 
Vad? 
Under 2 månader kommer länkar till en online-enkät att cirkulera på olika hbtq-hemsidor, forum, Facebook 
samt via e-post. Vi önskar sprida enkäten så mycket som möjligt för att alla som vill ska få en chans att 
deltaga en gång.  
 
Varför? 
Aktuell kunskap om hälsa och livsvillkor för transpersoner, som vi hoppas få genom den här enkäten, kan 
hjälpa till att förändra till det bättre. Vi hoppas genom enkäten att kunna identifiera de delar av hälsa och 
livsvillkor i samhället som fungerar bra och de som fungerar mindre bra, och den informationen kan sedan 




Genom att godkänna ditt medverkande längst ner på den här sidan, hänvisas du till en elektronisk enkät. 
Enkäten riktar sig till dig som är transperson eller har transerfarenhet samt har fyllt 15 år.   
Enkäten innehåller frågor om hur du mår och hur du upplever att du blir bemött i samhället. 
Enkäten tar cirka 15-30 minuter att fylla i.  
Frågorna har bearbetats i samarbete med RFSL, RFSL Ungdom och forskare på Karolinska Institutet för att 
vara så aktuella och relevanta som möjligt. Enkätens svar kommer senare i höst att sammanställas och nästa år 
publiceras som en rapport som kommer att vara tillgänglig på Folkhälsomyndighetens hemsida.    
 
Säkerhet och anonymitet 
Enkäten är helt anonym och deltagande är helt frivilligt. Det finns inga som helst möjligheter att dina svar kan 
kopplas till dig som individ och inga uppgifter som kan identifiera dig sparas. Du kan när som helst avbryta 
ditt deltagande. Informationen som samlas in via enkäterna sparas på en skyddad server och resultaten 
kommer enbart att presenteras på så kallad gruppnivå. Det betyder att man slår ihop alla svar på samma fråga 
och presenterar ett gruppresultat, istället för en enskild individs svar.  
 
Vem är ansvarig? 
Karolinska Institutet genomför studien på uppdrag av Folkhälsomyndigheten. Studien är ett samarbete mellan 
Karolinska Institutet, Folkhälsomyndigheten, RFSL och RFSL Ungdom. Forskningsansvarig för enkäten är 
professor Anna Ekéus Thorson.  
Om du har frågor om enkäten och/eller om studien, vänd dig till forskningsassistent Galit Zeluf på telefon 
0735-208821 eller mejla till galit.zeluf.1@ki.se 
 
Samtycke till deltagande i studien  
Jag har härmed fått skriftlig information om studien ”Hälsa och livssituation hos transpersoner i Sverige” och 
samtycker att delta i studien. Jag vet att min medverkan är frivillig och att mina svar är helt anonyma. Jag är 
15 år eller äldre  
 
 Ja  
 Nej  
 
